https://rjrindex.com/articles/dose-modifications-toxicity-and-survival-with-enfortumab-vedotin-plus-pembrolizumab-evp-in-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-vav1-on-metastasis-and-immune-evasion-in-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-exercise-based-interventions-for-the-management-of-chemotherapy-induced-peripheral-neuro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-of-novel-cd8-immune-epitopes-relevant-for-ebv-related-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/canassist-breast-in-routine-clinical-care-a-real-world-single-centre-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glucagon-like-peptide-1-receptor-agonists-glp-1-ra-versus-statins-and-the-risk-of-hepatocellular-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-of-cabozantinib-in-combination-with-pemetrexed-and-carboplatin-followed-by-pemet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-preference-for-large-language-model-llm-optimised-oncology-trial-information-a-randomised 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analytical-validation-of-a-90-gene-expression-assay-for-pan-cancer-tissue-of-origin-classification-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mechanistically-guided-therapeutic-strategy-for-bap1-mutant-tumors-through-protein-stability-and-chr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-comparative-effectiveness-and-safety-of-sotorasib-versus-adagrasib-in-previously-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ebv-dna-dynamics-guide-post-local-therapy-ici-consolidation-in-stage-ii-iii-pulmonary-lymphoepitheli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-integrative-multi-omics-machine-learning-framework-for-precision-metastasis-prediction-and-clinic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-a-high-speed-knowledge-based-ai-tool-at-the-primary-care-level-with-zero-miss-triage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-cell-multi-omic-atlas-of-extrahepatic-cholangiocarcinoma-progression-with-st6gal1-enriched 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expectations-and-unmet-needs-of-cancer-patients-seeking-ayurved-rasayana-therapy-a-cross-sectional 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-profiling-of-adolescent-and-young-adult-cancers-in-asia-a-scoping-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-mutation-status-of-kras-nras-and-braf-genes-in-stage-iv-colorectal-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tofacitinib-for-immune-related-adverse-events-grade-3-induced-by-immune-checkpoint-inhibitors-a-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-non-invasive-lncrna-biomarker-model-for-detection-and-metastatic-risk-prediction-in-prostate-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-sex-related-non-immune-cell-crosstalk-in-the-tumor-microenvironment-on-skeletal-muscle-los 2026-08-24 monthly 0.7 https://rjrindex.com/articles/structural-modelling-of-germline-foxa1-variants-identified-in-asian-participants-with-incident-gastr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-first-line-modified-docetaxel-cisplatin-and-fluorouracil-mdcf-in-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-icu-outcomes-and-predictors-of-morbidity-and-mortality-in-cancer-patients-after-oncosu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-plus-rivoceranib-as-first-line-maintenance-therapy-after-camrelizumab-chemo-induction-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-testing-in-pancreatic-adenocarcinoma-a-retrospective-cohort-study-of-germline-genetic-test 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-as-a-clinical-teaching-co-pilot-a-real-world-evaluation-of-an-llm-integrated-bedside-microteachi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-of-first-line-pembrolizumab-plus-chemotherapy-nivolumab-plus-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/short-course-radiotherapy-and-chemotherapy-with-or-without-pd-l1-blockade-envafolimab-for-mss-loca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-based-prediction-of-icu-mortality-in-patients-with-pancreatic-cancer-a-mimic-iv-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/structural-determinants-of-diagnosis-and-prognosis-in-cervical-cancer-associations-between-care-set 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-ai-cdk46i-synergy-matrix-a-de-novo-meta-analysis-decoupling-aromatase-inhibitor-identity-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-clinical-and-biological-associations-between-multimodal-artificial-intelligence-mmai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-mutation-profiles-and-circulating-tumor-dna-detection-across-gastrointestinal-and-hepatobiliar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-efficacy-and-safety-of-camrelizumab-plus-apatinib-in-patients-with-refractory-chordoma-a-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-enrichment-using-decipher-and-pam50-luminal-b-to-optimize-neoadjuvant-immunotherapy-strategi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expanding-global-access-to-oncology-trials-mcode-aligned-ai-for-inclusive-patient-matching-across-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/innate-immune-cross-talk-of-glioblastoma-pathophysiology-understanding-nlrp3-and-nlrp12 2026-08-24 monthly 0.7 https://rjrindex.com/articles/family-based-cascade-screening-in-hereditary-breast-and-ovarian-cancer-identification-of-asymptomat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-role-of-mismatch-repair-status-in-stage-ii-colon-cancer-at-ho-chi-minh-city-oncology-hosp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeted-and-immunotherapy-strategies-in-biliary-tract-cancer-a-bayesian-network-meta-analysis-comp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-mortality-rates-by-educational-attainment-among-us-adults-aged-25-64-years-a-population-ba 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acute-skin-toxicity-comparison-of-adjuvant-two-weekly-accelerated-hypofractionated-versus-three-week 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inetetamab-combined-with-pyrotinib-for-neoadjuvant-treatment-of-her2-positive-locally-advanced-breas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-roles-of-jup-hmgb1-and-fasn-knockdown-using-pro-sirna-mediated-regulation-on-tra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/training-tomorrows-oncologists-impact-of-the-oncology-interest-group-at-the-benemerita-universidad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-copd-mean-lung-dose-and-longitudinal-exhaled-nitric-oxide-for-predicting-symptomatic-radi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-university-of-new-mexico-hepatobiliary-echo-a-scalable-model-for-multidisciplinary-cancer-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multimodal-prehabilitation-and-adherence-to-perioperative-chemotherapy-in-localized-gastroesophageal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mc220404-coordinated-nivolumab-and-intraperitoneal-il-2-for-gastric-cancer-with-peritoneal-metastasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-driven-mortality-analysis-of-three-major-neoplasms-in-mexico 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-first-line-palliative-treatments-in-advanced-biliary-tract-cancer-a-single-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-second-opinion-pathology-review-process-on-diagnostic-accuracy-in-sarcoma-experience-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/active-bone-marrow-sparing-imrt-guided-by-spectct-functional-imaging-to-reduce-hematologic-toxicity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-gan-based-multimodal-framework-for-preoperative-response-prediction-in-her2-negative-locally-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-pkpd-and-efficacy-data-of-liposomal-doxorubicin-and-exods-bio-engineered-exosomes-load 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-intersection-between-frailty-and-unmet-health-related-social-needs-establishing-the-complex-fra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bc008-1a-pd-1tigit-bispecific-antibody-in-recurrent-cns-who-grade-4-glioma-results-from-a-random 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survival-analysis-of-tnt-a-phase-ii-study-of-neoadjuvant-toripalimab-plus-nimotuzumab-com 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-and-safety-of-traditional-chinese-medicine-external-wash-combined-with-local-cooling-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-time-breath-volatile-organic-compound-analysis-to-detect-newly-diagnosed-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-of-the-hybrid-tumor-informed-and-tumor-agnostic-ctdna-testing-to-predict-breast-cancer-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-based-icu-mortality-prediction-across-hematologic-malignancy-subtypes-a-comparativ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tgfv-mediated-overexpression-of-podoplanin-serves-as-a-potential-diagnostic-biomarker-in-acute-promy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/yttrium-90-resin-microsphere-transarterial-radioembolization-in-unresectable-hepatocellular-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapy-for-stage-iv-non-small-cell-lung-cancer-with-driver-alterations-asco-living-guideline-vers-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-follow-up-of-jcog1008-a-randomized-phase-iiiii-trial-of-chemoradiotherapy-comparing-3-we 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-disitamab-vedotin-tislelizumab-and-s-1-in-her2-overexpressing-advanced-gastric-or-gastr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extending-the-role-of-radiation-in-oligometastatic-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dual-immunotherapy-in-the-neoadjuvant-interval-for-locally-advanced-rectal-cancer-a-new-hope 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-dual-checkpoint-blockade-beneficial-beyond-prolonging-chemoradiotherapy-to-surgery-interval-in-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/care-gap-identifying-and-bridging-barriers-in-primary-palliative-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/signal-worth-trusting-if-we-can-reproduce-it-clarifying-overall-response-rate-and-progression-free 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-treatment-switching-and-subsequent-therapy-confound-overall-survival-estimates-in-pharos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/malignant-adult-ovarian-germ-cell-tumors-an-international-multicenter-study-to-identify-relevant-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expert-opinion-on-the-diagnosis-and-treatment-of-hematologic-malignancies-during-pregnancy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-regorafenib-in-newly-diagnosed-and-recurrent-glioblastoma-gbm-agile-phase-iiiii-baye 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cracks-in-the-estrogen-carcinogenesis-of-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ficerafusp-alfa-bca101-with-pembrolizumab-for-recurrent-or-metastatic-head-and-neck-squamous-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapy-for-stage-iv-non-small-cell-lung-cancer-without-driver-alterations-asco-living-guideline-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-switching-and-subsequent-therapy-confound-overall-survival-estimates-in-pharos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multicenter-randomized-phase-ii-trial-of-olaparib-plus-radium-223-versus-radium-223-in-men-with-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-single-cycle-pembrolizumab-for-stage-i-iii-mmr-deficient-colon-cancer-the-reset-c-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-signal-worth-trusting-if-we-can-reproduce-it-clarifying-overall-response-rate-and-progres 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapy-for-stage-iv-non-small-cell-lung-cancer-with-driver-alterations-asco-living-guideline-2026 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-efficacy-and-safety-of-taletrectinib-in-patients-with-iros1i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/menopausal-hormone-therapy-after-breast-cancer-personalization-not-prohibition 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lessons-from-gbm-agiles-regorafenib-experience-in-newly-diagnosed-and-recurrent-glioblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sustaining-high-reliability-amid-artificial-intelligence-adoption-in-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-intralesional-daromun-l19il2l19tnf-in-resectable-locally-advanced-melanoma-an-update-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-outcomes-from-stamp-surgically-treated-adjuvant-merkel-cell-carcinoma-with-pembrolizumab-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-lenalidomide-plus-rituximab-for-relapsedrefractory-indolent-non-hodgkin-lymphoma-5-year-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-open-label-phase-3-study-of-gedatolisib-fulvestrant-palbociclib-vs-standard-of-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-randomized-open-label-study-of-tunlametinib-plus-vemurafenib-versus-investigators-cho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-results-of-comppare-a-prospective-comparison-of-outcomes-with-proton-and-photon-radiation-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-asandeutertinib-versus-osimertinib-as-first-line-treatment-in-egfr-mutated-ns 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-sintilimab-capecitabine-versus-capecitabine-alone-in-locoregionally-advanced-nasopharyngeal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-phase-ii-trial-of-ahcc-combined-with-multidisciplinary-treatment-for-resect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sunvozertinib-monotherapy-versus-platinum-based-chemotherapy-as-first-line-treatment-for-advanced-ns 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nhs-galleri-primary-results-from-a-randomised-controlled-trial-to-assess-the-clinical-utility-of-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-interim-analysis-of-swog-s1823-operating-characteristics-of-circulating-microrna-371a-3p-mir 2026-08-24 monthly 0.7 https://rjrindex.com/articles/giredestrant-gire-palbociclib-palbo-vs-letrozole-let-palbo-as-first-line-1l-therapy-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pathological-complete-response-and-ctdna-analyses-in-science-results-from-a-randomized-phase-iii-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-3-clinical-trial-of-the-combination-of-erlotinib-plus-ramucirumab-compared-with-osimertinib-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-molecular-complexity-to-personalized-care-in-chronic-myelomonocytic-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/node-sparing-modified-short-course-radiotherapy-combined-with-capox-and-tislelizumab-versus-conventi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-hepatic-arterial-infusion-pump-chemotherapy-with-floxuridine-for-patients-with-resectable-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frontmind-phase-3-study-of-tafasitamab-tafa-plus-lenalidomide-len-and-r-chop-for-patients-pts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/her2climb-05-a-phase-iii-study-of-tucatinib-versus-placebo-in-combination-with-trastuzumab-and-pert 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-gap-advancing-first-line-therapy-for-patients-with-metastatic-human-epidermal-growth-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-neoadjuvant-versus-adjuvant-chemotherapy-dose-density-and-treatment-schedule-in-biological 2026-08-24 monthly 0.7 https://rjrindex.com/articles/progression-free-survival-after-next-line-of-treatment-pfs2-and-subsequent-therapies-subs-tx-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nationwide-randomized-phase-iii-placebo-controlled-trial-of-bupropion-for-cancer-related-fatigue 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quizartinib-for-newly-diagnosed-iflt3i-internal-tandem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/yttrium-90-radioembolization-provides-durable-local-control-and-definitive-radiation-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mezigdomide-carfilzomib-and-dexamethasone-mezikd-vs-carfilzomib-and-dexamethasone-kd-in-relaps 2026-08-24 monthly 0.7 https://rjrindex.com/articles/darovasertib-plus-crizotinib-vs-investigators-choice-as-first-line-treatment-for-patients-with-hla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disease-free-survival-dfs-and-time-to-recurrence-ttr-with-circulating-tumor-ct-dna-based-decis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iii-chipro-study-of-chiauranib-plus-weekly-paclitaxel-for-platinum-resistant-or-refractory-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-yttrium-90-radioembolization-provides-durable-local-control-and-definitive-radiation-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sarc041-a-phase-3-randomized-double-blind-study-of-abemaciclib-versus-placebo-in-patients-with-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-fruquintinib-combined-with-chemotherapy-versus-bevacizumab-combined-with-chem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adam-trial-a-multicenter-randomized-double-blinded-placebo-controlled-phase-3-trial-of-adjuvant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-i-study-of-sigvotatug-vedotin-an-integrin-beta-6-directed-antibody-drug-conju 2026-08-24 monthly 0.7 https://rjrindex.com/articles/room-402 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-based-ecosystem-to-improve-personalized-medicine-in-chronic-myelomonocytic-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-taxane-plus-trastuzumab-and-pertuzumab-with-or-without-carboplatin-in-human-epidermal-gr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-1l-camizestrant-cami-for-emergent-iesr1i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/osimertinib-withwithout-chemotherapy-in-patients-with-persistent-ctdna-egfr-mutant-egfrm-nsclc-at 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reply-to-quizartinib-for-newly-diagnosed-iflt3i-inter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/izalontamab-brengitecan-iza-bren-versus-physicians-choice-of-chemotherapy-in-patients-with-unrese 2026-08-24 monthly 0.7 https://rjrindex.com/articles/support-digital-self-management-and-clinical-support-for-advanced-cancer-a-randomized-controlled-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/daraxonrasib-a-rason-multi-selective-inhibitor-vs-chemotherapy-in-previously-treated-metastatic-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breakwater-progression-free-and-overall-survival-analyses-of-first-line-1l-encorafenib-cetuxima 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-open-label-parallel-controlled-phase-3-trial-of-benmelstobart-plus-chemotherapy-and-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ramelteon-for-prevention-of-postoperative-delirium-in-elderly-cancer-patients-a-randomized-double 2026-08-24 monthly 0.7 https://rjrindex.com/articles/concurrent-thoracic-radiotherapy-trt-platinumetoposide-chemotherapy-and-durvalumab-immunotherap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/event-free-survival-with-adjuvant-selpercatinib-in-stage-ib-iiia-ireti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ultra-low-dose-immunotherapy-plus-oral-metronomic-chemotherapy-versus-paclitaxel-carboplatin-in-plat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ivonescimab-plus-chemotherapy-versus-tislelizumab-plus-chemotherapy-in-previously-untreated-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-aspirin-for-stage-iii-colorectal-cancer-after-curative-resection-primary-analysis-of-the-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anbenitamab-plus-albumin-bound-docetaxel-nab-docetaxel-carboplatin-cb-versus-trastuzumab-and-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/erratum-evaluation-of-regorafenib-in-newly-diagnosed-and-recurrent-glioblastoma-gbm-agile-phase-ii 2026-08-24 monthly 0.7 https://rjrindex.com/articles/durvalumab-monotherapy-versus-active-monitoring-for-resected-primary-renal-cell-carcinoma-in-rampart 2026-08-24 monthly 0.7 https://rjrindex.com/articles/talapro-3-talazoparib-tala-enzalutamide-enza-compared-with-placebo-pbo-enza-for-the-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-dosimetry-of-sup177sup-lu-rosopatamab-tetrax 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemoradiotherapy-versus-neoadjuvant-chemotherapy-followed-by-d2-gastrectomy-and-adjuvan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/amivantamab-monotherapy-in-chemorefractory-irasi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/selinexor-plus-ruxolitinib-in-jak-inhibitor-naive-myelofibrosis-phase-3-sentry-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disitamab-vedotin-dv-plus-toripalimab-tor-and-chemotherapy-chemotrastuzumab-tra-for-first-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/low-dose-pembrolizumab-with-chemotherapy-in-advanced-nsclc-a-phase-3-randomized-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-results-from-emerald-3-a-phase-3-randomized-study-of-tremelimumab-plus-durvalu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/durvalumab-in-combination-with-neoadjuvant-chemotherapy-in-early-triple-negative-breast-cancer-long 2026-08-24 monthly 0.7 https://rjrindex.com/articles/matrix-a-randomized-phase-ii-trial-of-tuvusertib-atr-inhibitor-with-or-without-avelumab-in-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/palbociclib-plus-tamoxifen-goserelin-in-women-with-hormone-receptor-hr-positive-her2-negative-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-controlled-open-label-phase-ii-trial-of-autologous-tumor-infiltrating-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-injection-site-reaction-immune-response-results-from-open-label-arm-of-ongoing-phase-iii 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethical-design-and-implementation-of-monetary-transfer-interventions-in-clinical-cancer-research 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gabapentin-plus-tramadol-versus-tramadol-alone-for-chemoradiotherapy-induced-oral-mucositis-pain-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-results-of-the-better-care-trial-implementation-of-a-needs-adapted-and-individualized-follo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-rilvegostomig-r-trastuzumab-deruxtecan-t-dxd-in-high-risk-her2-negative-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/omission-of-completion-axillary-dissection-in-patients-with-breast-cancer-and-sentinel-lymph-node-ma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-results-of-a-randomized-controlled-phase-3-trial-comparing-resection-and-post-operative-ster 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-performance-results-from-pathfinder-2-a-registrational-study-of-a-multi-cancer-early-det 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-neoadjuvant-and-adjuvant-apalutamide-apa-androgen-deprivation-therapy-adt-vs-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rise-and-fall-of-neoadjuvant-carboplatin-for-human-epidermal-growth-factor-receptor-2-positive-breas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/headwinds-in-breast-cancer-research-the-case-for-pragmatic-radiotherapy-de-escalation-studies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reducedno-dexamethasone-with-netupitantpalonosetron-and-olanzapine-for-chemotherapyinduced-nausea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/resistance-to-immune-checkpoint-inhibitor-treatment-in-non-small-cell-lung-cancer-clinical-trials-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/associations-of-autoimmune-diseases-with-appendiceal-cancer-in-a-population-based-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-trends-and-factors-affecting-survival-in-thymic-carcinoma-insights-from-seer-data 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-feasibility-of-intratumoral-injection-of-rp1-or-rp2-oncolytic-immunotherapies-in-visceral 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-ai-informed-morphologic-and-spatial-transcriptomics-features-from-hampe-slides-to-enabl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-enumeration-of-circulating-tumor-cells-with-pd-l1-overexpression-using-anti-epcam-antibo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-venous-thromboembolism-in-resectable-non-small-cell-lung-cancer-treated-with-neoadjuvant-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-menopausal-status-on-the-efficacy-of-adjuvant-cdk46-inhibitors-in-hormone-receptor-pos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-costs-of-care-and-discontinuation-among-patients-receiving-adjuvant-cdk46-inhibitors-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-in-hospital-mortality-and-palliative-care-utilization-in-metastatic-renal-cell-carcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-baseline-clinical-factors-and-treatment-related-variables-with-survival-in-phase-i-so 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ql1706-combined-with-nab-paclitaxel-and-gemcitabine-as-first-line-treatment-for-locally-advanced-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-carbon-tetrachloride-with-lung-cancer-incidence-and-mortality-including-effects-in-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-cosibelimab-800-mg-every-2-weeks-for-locally-advanced-cutaneous-squamous-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-response-adapted-and-genomically-informed-strategy-to-optimize-neoadjuvant-chemotherapy-versus-end 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncology-drug-shortages-and-disruptions-to-cancer-treatment-delivery-in-mexico-a-national-oncologis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-of-economic-measures-and-patient-outcomes-with-geographical-disparities-in-access-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-nccn-guided-training-on-large-language-model-performance-in-mnsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cell-free-dna-fragmentomics-as-an-enabler-of-tumor-of-origin-classification-using-a-commercial-targe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prime-rose-a-blueprint-for-implementing-precision-cancer-medicine-in-europe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-early-cognitive-decline-with-compromised-delivery-of-adjuvant-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cell-free-dna-fragmentomics-and-methylomics-for-thymic-epithelial-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoantigen-prediction-and-reactivity-of-cerebrospinal-fluid-human-derived-tumor-reactive-t-cells-cs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-iii-study-of-pembrolizumab-versus-pembrolizumab-with-carboplatin-plus-pemetrexed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-cadonilimab-plus-capeox-in-patients-with-clinical-stage-iii-gastric-or-esophagogastric-j 2026-08-24 monthly 0.7 https://rjrindex.com/articles/non-invasive-strategy-for-gastric-cancer-detection-integration-of-cell-free-dna-fragmentomics-and-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-specific-trends-and-outcomes-in-small-cell-lung-cancer-sclc-in-spain-insights-from-the-claris 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-immune-remodeling-linked-to-obesity-with-immunotherapy-outcomes-in-cholangiocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cxcl12-supsup-pericytes-as-drivers-of-lymphatic-dissem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-impact-of-baseline-and-peri-treatment-concomitant-medication-exposure-and-polypharmacy-on-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-clinical-success-and-adverse-events-with-endoscopic-ultrasound-guided-biliary-drainage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-treatment-outcomes-in-ductal-and-intraductal-prostate-cancer-insights-from-the-nation 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-efficacy-of-dalpiciclib-and-nonsteroidal-aromatase-inhibitors-nsais-in-estrogen-receptor-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-a-patient-facing-digital-tool-for-glioblastoma-outside-scheduled-clinic-visits 2026-08-24 monthly 0.7 https://rjrindex.com/articles/addressing-health-related-social-needs-for-cancer-patients-an-implementation-assessment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapeutic-strategies-and-reduced-drug-spending-as-a-signal-of-early-impact-of-the-enhancing-oncolo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-tumor-recurrence-dynamics-in-patients-with-hrher2-advanced-breast-cancer-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b-study-of-sys6002-in-advanced-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-first-line-enfortumab-vedotin-plus-pembrolizumab-in-metastatic-urothelial-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-perioperative-cadonilimab-ak104-in-patients-with-recurrent-resectable-head-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-a-tissue-based-predictive-rna-test-for-immunotherapy-benefit-in-nsclc-the-predapt-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-associated-differences-in-genomic-profiles-among-patients-with-pancreatic-cancer-undergoing-next 2026-08-24 monthly 0.7 https://rjrindex.com/articles/large-language-model-guided-extraction-of-explainable-clinical-decision-trees-from-longitudinal-meni 2026-08-24 monthly 0.7 https://rjrindex.com/articles/usp10-activity-as-sensitizer-of-lung-adenocarcinoma-to-immune-checkpoint-inhibitors-upregulating-pd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognosis-and-management-of-dcis-withwithout-microinvasion-retrospective-analysis-from-seer-and-cs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multiple-myeloma-incidence-prevalence-and-mortality-burden-in-the-united-states-retrospective-epi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemokine-modulation-of-the-tumor-microenvironment-tme-in-resectable-metastatic-colore 2026-08-24 monthly 0.7 https://rjrindex.com/articles/empowering-educators-an-international-virtual-mentorship-program-for-hematologyoncology-medical-ed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-non-treatment-following-pancreatic-cancer-diagnosis-in-the-united-states-a-population 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-onboard-tethered-il-12-on-potency-of-the-tmod-not-gate-and-selectivity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-the-tetravalent-death-receptor-5-agonist-ozekibart-inbrx-109-combined-with-chemot 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-fruquintinib-combined-with-cadonilimab-in-refractory-msspmmr-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shr-a2102-in-combination-with-adebrelimab-as-first-line-treatment-in-patients-with-locally-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-of-male-breast-cancer-in-brazil-comprehensive-genomic-characterization-of-a-lat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-gut-microbiota-derived-testosterone-on-distant-metastasis-in-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hospitalized-oncology-patients-with-diarrhea-clinical-outcomes-and-prognostic-factors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-microenvironment-modulation-by-losartan-in-advanced-gallbladder-cancer-gbc-results-and-geno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-a-financial-navigation-intervention-on-financial-toxicity-among-patients-with-breast-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-pancreatic-cancer-risk-in-rheumatoid-arthritis-and-role-of-rheumatoid-factor-test-a-retro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/noninvasive-imaging-biomarkers-for-survival-risk-stratification-with-tarlatamab-in-es-sclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cabozantinib-in-high-grade-neuroendocrine-neoplasms 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-adaptive-versus-continuous-dosing-of-encorafenib-and-binimetinib-in-combination-with-nivolumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survival-outcomes-of-consolidative-local-ablative-therapy-after-response-to-first-line-sys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/secondary-genomic-alterations-and-clinical-outcomes-in-myxoid-liposarcoma-a-multi-institutional-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-surufatinib-combined-with-gemcitabine-and-cisplatin-and-immune-checkpoint-inhibit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-and-safety-of-systemic-therapies-in-high-risk-hormone-sensitive-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shifting-drivers-of-hospitalization-in-endometrial-cancer-toxicity-like-organ-failure-phenotypes-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-tai-chi-qigong-on-gene-expression-profiles-in-older-male-cancer-survivors-with-fatigue 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-mediation-analysis-of-neurocognitive-deficits-and-patient-reported-mood-among-patients-with-lung-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lif-expression-as-a-predictive-biomarker-in-metastatic-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-muscle-quantity-and-quality-for-overall-survival-in-non-metastatic-castra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-tp53-co-mutation-and-interleukin-gene-expression-in-egfr-mutant-advanced-lung-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-fractionated-radiotherapy-scart-remodeling-of-the-tumor-immune-microenvironment-and-change 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiation-for-oligoprogression-to-prolong-systemic-therapy-experience-from-early-drug-development-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-transcriptomic-profiling-of-the-tumor-microenvironment-associated-with-sunitinib-response-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-gfpt2-expression-with-clinical-outcomes-in-clear-cell-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/target-specific-therapy-for-actionable-and-approved-tumor-agnostic-biomarkers-influence-on-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-performance-of-serum-pivka-ii-alone-and-in-combination-with-afp-for-hepatocellular-carcin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-genomic-and-quantitative-ihc-driven-target-identification-to-enable-precision-tumor-select 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-smoking-status-on-risk-of-mortality-for-patients-with-lung-cancer-treated-with-immunothera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/associated-antitumor-effects-of-oncoytic-vaccinia-virus-expressing-a-tethered-il-12il-2-fusion-cyto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-rna-based-immune-gene-expression-with-immunotherapy-duration-in-advanced-non-small-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aky-2519-a-novel-b7-h3-targeted-radioconjugate-and-its-biodistribution-profile-in-patients-with-mc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/knowledge-of-hpv-related-penile-cancer-among-us-men-socioeconomic-differences-and-divergence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-endotoxin-to-engineered-agonists-a-translational-strategy-to-enable-tlr4-based-immunomodulatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-antibody-drug-conjugates-in-gastrointestinal-malignancies-a-systematic-revie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/embedding-patient-priorities-into-clinical-research-co-developing-access-drug-navigation-and-comm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-cost-effectiveness-of-androgen-receptor-pathway-inhibitors-for-metastatic-hormone-sensiti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ascent-04-analysis-of-efficacy-by-biomarker-subgroups-with-sacituzumab-govitecan-sg-pembrolizum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-responders-to-sacituzumab-govitecan-in-metastatic-triple-negative-breast-cancer-real-worl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-the-livit-regimen-liposomal-irinotecan-vincristine-and-temozolomide-in-pediatri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-ct-based-deep-learning-derived-consensus-molecular-subtypes-with-survival-outcomes-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-two-axis-machine-learning-framework-for-cell-of-origin-inference-in-aml-a-proof-of-concept-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/arrhythmia-phenotype-and-30-day-readmission-in-selected-cancers-propensity-matched-nrd-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nilvanstomig-zg005-an-anti-pd-1tigit-bispecific-antibody-plus-bevacizumab-vs-sintilimab-plus-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/collaborative-education-to-advance-equitable-prostate-cancer-care-in-geographically-diverse-communit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differences-in-central-versus-local-lab-pd-l1-classification-in-the-alchemist-alliance-a151216-non-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-perioperative-ctdna-monitoring-in-patients-with-esophageal-squamous-cell-carcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/external-validation-of-a-mmai-model-for-prognosis-and-chemotherapy-benefit-prediction-in-postmenopau 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-73-versus-azacitidinevenetoclax-in-cml-transformed-to-aml 2026-08-24 monthly 0.7 https://rjrindex.com/articles/belantamab-mafodotin-with-daratumumab-lenalidomide-and-dexamethasone-in-transplant-ineligible-new 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-combined-hcc-cholangiocarcinoma-with-adjuvant-chemotherapy-an-ncdb-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/defining-prostaglandin-driven-dysregulation-in-ipik3cai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-risk-and-screening-preventable-malignancies-in-transgender-populations-a-systematic-review-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/empegfilgrastim-for-primary-febrile-neutropenia-prophylaxis-during-induction-chemotherapy-with-docet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/benchmarking-free-energy-computational-methods-for-revealing-the-key-interactions-driving-parp1-sele 2026-08-24 monthly 0.7 https://rjrindex.com/articles/usp43-downregulation-as-driver-of-acquired-resistance-to-dabrafenib-and-trametinib-in-melanoma-via-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/site-and-extent-of-distant-metastasis-at-diagnosis-as-used-to-stratify-survival-in-head-and-neck-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-and-neighborhood-factors-associated-with-patient-survival-among-adolescents 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-black-versus-non-hispanic-white-women-with-stage-iv-her2-low-breast-cancer-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/facilitators-and-barriers-to-medicaid-services-for-childhood-cancer-survivors-perspectives-from-onc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-analysis-of-adjuvant-chemotherapy-after-radical-resection-of-metachronous-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-exposure-environmental-mapping-and-scale-effects-in-lung-cancer-risk-assessment-an-ecological 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-familiar-paradox-in-a-new-exposure-electronic-cigarettes-and-thyroid-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/audiometric-outcomes-for-intravenous-sodium-thiosulfate-for-cisplatin-induced-ototoxicity-prevention 2026-08-24 monthly 0.7 https://rjrindex.com/articles/high-risk-clinic-follow-up-after-genetic-counseling-and-testing-uptake-patterns-and-predictors-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/synergistic-probiotic-chemotherapy-remodeling-of-the-intratumoral-microbiome-as-a-driver-of-mature-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-in-melanoma-related-hospitalizations-admission-characteristics-and-in-hospital-out 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-hereditary-cancer-genetic-testing-programs-in-india-and-the-us-identifying 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gene-and-isoform-transcriptomics-to-uncover-distinct-immune-and-signaling-programs-across-sarcoma-su 2026-08-24 monthly 0.7 https://rjrindex.com/articles/living-after-lymphoma-a-retrospective-study-of-survivorship-outcomes-from-a-tertiary-cancer-centre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exclusive-neoadjuvant-chemotherapy-with-the-flot-regimen-protocol-in-resectable-gastric-cancer-a-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-nutritional-outcomes-assessed-by-subjective-global-assessment-in-community-oncology-pract 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-acute-kidney-injury-with-in-hospital-mortality-and-resource-utilization-among-us-so 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preferences-among-women-for-home-based-self-sampling-over-clinic-based-provider-collection-for-cervi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-visual-analogue-scale-vas-and-analgesia-administration-in-oncology-inpatients-an-audit-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-and-racial-disparities-in-cancer-related-mortality-among-individuals-with-substance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/soft-tissue-and-bonejoint-sarcoma-disaggregation-in-minorities 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-with-14-vs-28-day-monitoring-after-car-t-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-beach-culture-to-burden-analysis-of-skin-cancer-trends-in-australasia-using-the-gbd-database 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-comparative-risk-of-cardiovascular-complications-in-patients-receiving-immune-checkpoint-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-utilization-of-upfront-genomic-testing-in-newly-diagnosed-non-small-cell-lung-cancer-in-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-locoregional-treatments-in-oligometastatic-squamous-cell-anal-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-overall-survival-after-pd-1-failure-in-advanced-cutaneous-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/traditional-chinese-medicine-tcm-for-prevention-and-management-of-anti-egfr-monoclonal-antibody-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-serious-safety-reporting-signals-for-antibody-drug-conjugates-versus-her2-targeted-non-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/qualitative-assessment-of-barriers-and-facilitators-of-vagina-dilator-use-after-pelvic-radiotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/timing-of-statin-initiation-for-primary-atherosclerotic-cardiovascular-disease-ascvd-prevention-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-capox-as-part-of-total-neoadjuvant-therapy-for-high-risk-locally-advanced-rectal-cancer-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-stratified-outcomes-and-racial-disparities-in-hospitalized-patients-with-endometrial-cancer-a-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-menopausal-status-on-cognitive-function-and-sleep-in-breast-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-high-risk-hpv-positivity-in-janakpur-nepal-implications-for-scalable-cervical-cancer-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/research-on-the-development-and-application-of-bundled-care-protocols-for-radiation-dermatitis-in-na 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-spectrum-and-clinical-outcomes-of-immune-related-adverse-events-in-227-consecutive-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-trends-and-subsite-variation-in-mucosal-melanoma-a-seer-database-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-characteristics-and-outcomes-of-gastroesophageal-cancer-treated-at-a-tertiary-ac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/guideline-concordant-cancer-screening-among-us-adults-with-and-without-cardiovascular-risk-factors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-utilization-of-a-patient-centric-symptom-management-guide-for-metastatic-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-risk-stratification-for-sarcopenia-in-a-pan-cancer-cohort-using-quantile-regression-forests-on 2026-08-24 monthly 0.7 https://rjrindex.com/articles/creating-affordable-and-accessible-cancer-care-at-scale-history-of-extension-from-12-to-750-distric 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-impact-of-post-transplant-tyrosine-kinase-inhibitor-therapy-in-chronic-myeloid-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disproportionate-reporting-of-severe-gastrointestinal-injury-with-ruxolitinib-among-jak-inhibitors-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-trends-in-leukemia-related-disability-adjusted-life-years-and-mortality-across-socio-demograp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-biomarker-guided-multidisciplinary-management-in-localized-and-metastatic-gas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/learning-from-the-literature-an-ai-assisted-bayesian-framework-for-evidence-driven-oncology-trial-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-alterations-to-inform-anatomical-based-prognosis-for-recurrence-prediction-in-hnscc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-study-of-sacituzumab-govitecan-in-patients-with-previously-treated-extensive-stage-small-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-177lu-prrt-experience-in-a-lower-middle-income-country-lmic-treatment-delivery-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/envelope-trial-ncch2412-enfortumab-vedotin-in-patients-with-locally-advanced-or-metastatic-small 2026-08-24 monthly 0.7 https://rjrindex.com/articles/selective-bladder-sparing-trial-with-sasanlimab-as-maintenance-treatment-based-on-clinical-response 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-trial-in-progress-phase-ii-trial-of-neoadjuvant-tebentafusp-in-patients-with-locally-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-adjuvant-s-1-vs-capecitabine-plus-oxaliplatin-xelox-chemotherapy-among-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncological-outcomes-in-post-menopausal-women-with-kallmann-syndrome-a-propensity-matched-study-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bevacizumab-plus-encorafenib-cetuximab-in-braf-v600e-mutated-metastatic-colorectal-cancer-mcrc-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-phase-i-clinical-trial-evaluating-the-safety-tolerability-and-preliminary-efficac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-rainspot-a-multicentric-open-label-trial-of-zolbetuximab-paclitaxel-ramucirumab-in-second 2026-08-24 monthly 0.7 https://rjrindex.com/articles/contemporary-real-world-outcomes-of-mantle-cell-lymphoma-in-colombia-results-from-an-expanded-multi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-iii-trial-of-chemo-immunotherapy-vs-immunotherapy-alone-for-the-vulnerable-older 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psychosocial-interventions-in-the-care-of-individuals-with-hereditary-cancer-risk-a-scoping-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-economic-outcomes-associated-with-inpatient-palliative-care-in-hospitalized-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-non-covalent-btk-inhibitors-a-systematic-review-focused-on-indolent-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/electrolyte-abnormalities-and-arrhythmia-associated-inpatient-deterioration-in-hospitalized-cancer-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geodemographic-trends-and-disparities-in-liver-cancer-and-sepsis-related-mortality-among-adults-aged 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-from-malignant-neoplasms-and-alzheimers-dementia-in-adults-aged-55-and-older-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/life-course-epidemiology-of-body-size-and-risk-of-early-and-advanced-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combined-therapy-using-gemcitabine-and-cisplatin-chemotherapy-lenvatinib-and-adebrelimab-for-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nutritional-care-practices-in-oncology-services-in-senegal-a-multicenter-health-services-research-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-duration-of-response-as-an-interpretable-endpoint-in-non-small-cell-lung-cancer-drug-approval 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitors-and-molecular-targeted-agents-with-or-without-transarterial-chemoemboli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-treatment-sequencing-effects-in-well-differentiated-grade-3-gastroenteropancre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-transcript-based-her2-quantification-in-classification-and-determining-therapeutic-eligibili 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-non-epithelial-ovarian-malignancies-in-patients-younger-than-51-from-2004-to-2022-in-the-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-didactics-simulation-based-education-in-hematologyoncology-training-a-scoping-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-cancer-education-and-safety-in-rural-communities-through-a-digital-literacy-platform 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-multidisciplinary-care-in-the-treatment-of-muscle-invasive-bladder-cancer-a-quality-impro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-pilot-study-of-afatinib-re-challenge-in-patients-with-iegfri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-clinicopathological-and-molecular-profiling-study-of-iegfri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/short-term-financial-toxicity-in-car-t-cell-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-profiling-and-clinical-utility-of-csf-derived-cell-free-dnarna-for-evaluation-of-soli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-lorlatinib-in-stage-iii-nsclc-harboring-alk-fusion-a-phase-2-multicenter-study-lorin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sup18sup-f-fluoroestradiol-petct-to-guide-second-li 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modernizing-injectable-cancer-care-delivery-a-telemedicine-supported-home-injection-model-for-breas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-open-label-phase-3-study-of-zl-1310-a-dll3-antibody-drug-conjugate-adc-compared-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-concurrent-glp-1-receptor-agonist-use-with-survival-outcomes-in-patients-with-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1ab-study-of-rgt-61159-an-oral-myb-splicing-modulator-in-patients-with-advanced-adenoid-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-chronic-kidney-disease-on-toxicity-patterns-and-economic-burden-in-car-t-cell-therapy-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shr-a2102-a-nectin-4-targeted-antibody-drug-conjugate-combined-with-hrs-4642-in-previously-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-experience-with-inotuzumab-ozogamicin-in-high-risk-and-rr-b-cell-acute-lymphoblastic-leu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metastatic-trajectories-in-non-small-cell-lung-cancer-guide-local-and-systemic-therapies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biology-driven-lead-time-considerations-for-endocrine-therapy-de-escalation-in-elderly-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cervical-cancer-epidemiology-in-high-income-nations-1990-2023-three-decades-of-prevention-success 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-of-tazemetostat-in-epithelioid-sarcoma-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-safety-and-efficacy-of-trc003-in-metastatic-triple-negative-breast-cancer-a-prosp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/forecasting-the-head-and-neck-cancer-burden-in-vietnam-projections-from-the-hanoi-cancer-registry 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perceptions-of-supportive-care-among-patients-with-stage-iv-or-recurrent-cancer-in-a-community-oncol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-tyrosine-kinase-inhibitor-therapy-for-unresectable-locally-advanced-thyroid-cancer-a-sy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/registry-based-machine-learning-in-sezary-syndrome-assessment-of-prognostic-signal-and-age-masked-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-care-experiences-among-sexual-and-gender-minority-adults-a-qualitative-descriptive-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-perspectives-on-active-surveillance-and-machine-learning-driven-risk-stratification-for-low 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rural-urban-survival-differences-in-advanced-non-small-cell-lung-cancer-in-the-modern-treatment-era 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-survival-quality-of-life-and-symptoms-burden-among-underprivileged-breast-cancer-patients-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intraoperative-indocyanine-green-fluorescence-angiography-to-reduce-anastomotic-leak-after-esophagec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-and-clinical-relevance-of-janus-kinase-2-jak2-mutation-in-myelodysplasticmyeloprolifer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-of-regn5668-a-muc16cd28-costimulatory-bispecific-antibody-in-combination-with-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-real-world-progression-free-survival-rwpfs-in-patients-pts-with-epithelial-ovarian 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-among-us-adults-with-breast-cancer-and-hypertensive-diseases-a-nationwide-cdc-wo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-and-racial-disparities-in-anal-squamous-cell-carcinoma-outcomes-a-population-based 2026-08-24 monthly 0.7 https://rjrindex.com/articles/debio-0123-zedoresertib-a-selective-wee1-inhibitor-in-combination-with-carboplatin-in-adult-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/new-options-for-platinum-resistant-ovarian-cancer-are-we-in-the-right-direction 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-interventional-radiology-into-melanoma-care-a-quality-improvement-initiative-to-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/modified-monobenzone-supercarriers-as-targeted-therapies-for-metastatic-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-a-resident-led-quality-improvement-intervention-on-colorectal-cancer-screening-completion 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ahr-as-a-coupler-of-tryptophan-metabolism-to-immune-checkpoint-regulation-in-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-utility-of-liquid-biopsy-in-nsclc-in-a-community-oncology-practice-concordance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pan-cancer-multi-omic-integration-for-identification-of-clinically-aggressive-and-potentially-action 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-response-to-neoadjuvant-dose-dense-chemotherapy-in-luminal-breast-cancer-using-a-genom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemotherapy-and-individualized-de-escalation-surgery-for-fertility-preservation-in-stag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-clinical-study-of-nimotuzumab-plus-s-1-and-concurrent-radiotherapy-in-75-years-and-older-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eu-open-a-novel-approach-for-generating-european-oncology-real-world-evidence-at-scale 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-based-pre-screening-of-ibrca12i-mutation-likelihood 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transportation-access-as-a-structural-determinant-of-quality-of-life-and-symptom-burden-among-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interim-results-from-a-prospective-phase-ii-study-of-stratified-treatment-of-localized-cervical-esop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accelerated-diagnostic-pathway-for-undifferentiated-malignancy-via-interventional-radiology-triage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-mesutoclax-icp-248-in-combination-with-orelabrutinib-in-patients-with-b-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-sup18sup-f-fluoromisonidazole-pos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-price-of-a-breath-the-economic-and-mortality-burden-of-checkpoint-inhibitor-pneumonitis-2016-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-and-survival-outcomes-for-zanubrutinib-zanu-and-acalabrutinib-acala-monothe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preoperative-endocrine-treatment-response-in-primary-postmenopausal-endometrial-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psg-copy-number-amplification-and-association-with-poor-survival-in-early-stage-female-lung-adenocar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/participation-of-older-adults-aged-65-years-in-swog-cancer-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-with-sustained-minimal-residual-disease-mrd-negativity-in-belantamab-mafodotin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-ibii-study-of-enzalutamide-enza-with-and-without-ribociclib-rib-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-investigator-initiated-trial-iit-of-go306-injection-a-recombinant-oncolytic-vaccinia-virus-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-overall-survival-results-from-a-randomized-phase-iii-trial-of-non-cross-resistant-adjuvant-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determinants-of-triple-negative-breast-cancer-among-african-patients-early-results-from-the-african 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-watch-and-wait-on-fear-of-recurrence-in-rectal-cancer-a-multicenter-cross-sectional-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preoperative-combination-radiotherapy-rt-and-immune-checkpoint-inhibitor-ici-in-early-stage-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-a-phase-ii-study-to-evaluate-the-efficacy-and-safety-of-disitamab-vedotin-rc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liver-transplantation-lt-in-liver-limited-metastatic-colorectal-cancer-crc-insights-and-opportu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-controlled-phase-iii-trial-of-tpf-induction-chemotherapy-versus-pf-adjuvan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/late-line-treatment-in-hormone-receptor-positive-her-2-neu-positive-metastatic-breast-cancer-with-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-propensity-score-matched-real-world-analysis-of-immune-checkpoint-inhibitors-in-melanoma-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/behavioral-risk-factor-attributable-burden-of-gastrointestinal-cancers-a-global-site-specific-quan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-targeted-therapy-versus-chemoimmunotherapy-in-lung-adenocarcinoma-a-dual-center-compara 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-multimodal-local-therapy-on-survival-in-gastric-cancer-leptomeningeal-metastases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determinants-of-cervical-cancer-awareness-procedural-knowledge-and-information-sources-among-nepal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zelenectide-pevedotin-bt8009-plus-pembrolizumab-in-1l-cisplatin-ineligible-locally-advancedmetast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fid-007-in-combination-with-cetuximab-in-recurrent-or-metastatic-rm-head-and-neck-squamous-cell-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expanding-cfdna-capture-beyond-nucleosome-sized-fragments-to-enhance-liquid-biopsy-performance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-phase-1-results-of-a-micab-targeted-car-t-cell-designed-to-overcome-solid-tumor-escape 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-to-integrating-obesity-management-into-cancer-survivorship-care-results-from-a-single-inst 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-concordance-of-tumor-mutational-burden-tmb-between-blood-circulating-tumor-dna-and-ti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/net-costs-associated-with-inpatient-ip-administration-of-step-up-dosing-sud-of-bispecific-antibo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-multi-omics-to-clinical-practice-bc-biomixer-to-predict-pcr-and-guide-individualized-neoadjuva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-significance-of-mdm-2-positivity-in-stage-4-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-treatment-induced-decrease-of-tumor-chromosome-y-and-prognosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intracellular-pharmacology-and-trafficking-to-support-sequential-activation-of-synchrolink-t2x-antib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-clearance-as-an-early-indicator-of-sotorasib-panitumumab-efficacy-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-end-of-life-immunotherapy-use-in-metastatic-head-and-neck-squamous-cell-carcinoma-a-natio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-risk-to-reward-redefining-the-role-of-glp-1-receptor-agonist-in-pancreatic-cancer-primary-prev 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-determinants-of-resistance-to-brafmek-inhibitors-in-ibrafi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/engineering-tumor-infiltrating-lymphocytes-tils-via-the-t-editor-platform-to-enhance-antitumor-act 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-lipid-lowering-therapy-initiation-after-lorlatinib-and-clinical-outcomes-in-non-small-cell-lun 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extreme-persistence-of-polyclonal-cd8-car-t-cells-as-a-driver-of-marrow-failure-neurotoxicity-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/large-scale-emr-based-machine-learning-for-early-risk-stratification-of-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-survival-and-safety-outcomes-of-tarlatamab-in-patients-with-extensive-stage-small-cell-lu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcome-of-chemotherapy-among-intubated-patients-with-small-cell-lung-cancer-a-systematic-review 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-line-immunotherapy-in-es-sclc-efficacy-and-safety-of-second-line-pd-1pd-l1-inhibitors-after 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-guideline-discordant-care-for-muscle-invasive-bladder-cancer-on-preventable-survival-losse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/platinum-chemotherapy-and-oncolytic-virotherapy-as-used-to-cooperatively-sustain-stem-like-cd8-t-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/thalamic-neuroepithelial-cysts-endoscopic-management-strategies-and-clinical-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-mutational-burden-by-smoking-status-in-small-cell-lung-cancer-insights-from-a-limited-cohort 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-circulating-tumor-dna-in-muscle-invasive-bladder-cancer-treated-with-radical-cys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survivorship-rates-among-previously-treated-advanced-melanoma-patients-achieving-objective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enrichment-of-the-germline-i-nlrc5 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-high-and-intermediate-risk-hormone-receptor-hr-positive-human-epidermal-growt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-treatment-patterns-and-outcomes-for-patients-with-germ-cell-tumor-and-bra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-value-of-genomic-mutation-signatures-and-tumor-mutational-burden-for-induction-immunochem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/monitoring-pd-l1-expression-in-circulating-cancer-associated-cells-for-prediction-of-clinical-outcom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-cr-sequence-trial-of-folfoxpanitumumab-followed-by-folfiribevacizumab-seq1-versus-folf 2026-08-24 monthly 0.7 https://rjrindex.com/articles/palliative-care-utilization-in-metastatic-lung-cancer-at-an-urban-safety-net-hospital 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-the-results-of-whole-exome-sequencing-of-paired-samples-in-patients-of-the-eurasian-popu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-candidate-jnc-1043-importin-ss-inhibitor-first-in-class-to-target-incurable-cancers-tnb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-holiday-for-patients-with-metastatic-hormone-sensitive-prostate-cancer-real-world-experie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-and-mortality-burden-of-lung-cancer-with-secondary-brain-and-meningeal-metastases-am 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-survival-understanding-unmet-needs-among-a-diverse-cohort-of-ovarian-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-assessment-of-interfractional-geometrical-variations-of-gastrointestinal-organs-in-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sbrt-versus-surgery-for-early-stage-nsclc-a-propensity-matched-systematic-review-meta-analysis-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-assessment-of-duffy-null-associated-neutrophil-counts-danc-status-and-impact-on-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/empowering-multidisciplinary-teams-in-cancer-survivorship-results-from-the-asco-project-echo-surviv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-expansion-of-advanced-practice-providers-over-5-years-at-hawaiis-nci-community-oncology-resea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-with-atezolizumab-versus-durvalumab-plus-chemotherapy-for-extensive-stage-small 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-rapid-th9tc9-polarized-car-t-manufacturing-platform-to-enable-metabolic-fitness-and-superio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-efficacy-and-safety-of-first-line-1l-nivolumab-plus-relatlimab-nivo-rela-versus-nivo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-localization-of-epithelial-mesenchymal-transition-and-immune-niches-in-non-small-cell-lung-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-organizational-benefits-of-remote-symptom-monitoring-during-injectable-outpatient-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breath-analysis-of-volatile-organic-compounds-with-mid-infrared-laser-spectroscopy-in-a-cohort-of-lu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multicenter-open-label-randomized-trial-of-the-utility-of-electronic-patient-reported-outcome-monito 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-pre-diagnosis-primary-care-utilization-with-metastatic-disease-treatment-adherence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-evaluation-of-sacituzumab-govitecan-in-platinum-resistant-ovarian-cancer-nct06028932 2026-08-24 monthly 0.7 https://rjrindex.com/articles/aps-tma-phenotypes-as-a-failure-to-rescue-signal-during-us-cancer-hospitalizations-national-inpat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vaccine-induced-immune-responses-hla-genotyping-and-molecular-profiling-in-patients-with-metastati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/yocas-yoga-mood-disturbance-and-insomnia-a-urcc-ncorp-rb-nationwide-phase-iii-randomized-contr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-and-clinical-correlates-of-belzutifan-treatment-in-renal-cell-carcinoma-rcc-a-retrospecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-neoadjuvant-disitamab-vedotin-dv-in-combination-with-toripalimab-tor-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-clinical-trial-evaluating-dual-targeting-car-t-cells-kd-496-against-cldn182-and-nkg2dl-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-trust-in-oncologists-versus-artificial-intelligence-for-cancer-related-questions 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pembrolizumab-infusion-timing-on-outcomes-in-early-stage-triple-negative-breast-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemoablation-with-oral-erdafitinib-in-recurrent-ifgfr3i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-tucatinib-tuc-vs-placebo-pbo-combined-with-trastuzumab-and-pertuzumab-hp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fatigue-and-psychostimulant-use-in-patients-with-advanced-cancer-in-an-oncology-palliative-care-clin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/necitumumab-plus-pembrolizumab-and-chemotherapy-for-untreated-advanced-squamous-nsclc-phase-iii-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-treating-fields-therapy-in-patients-with-newly-diagnosed-glioblastoma-and-poor-performance-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-frontline-treatment-patterns-for-multiple-myeloma-among-us-veterans-1999-2025 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extended-follow-up-6-years-of-the-phase-2-litespark-004-study-of-belzutifan-in-participants-with-v 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ff-10832-liposomal-gemcitabine-monotherapy-or-combination-with-pembrolizumab-in-patients-with-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-lif-and-lifr-expression-to-characterize-survival-and-tumor-microenvironment-composition-in-lu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-trial-to-evaluate-the-safety-and-tolerability-of-fb-pmt-in-patients-with-recurrent-glioblast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-hpv-dna-for-early-detection-of-minimal-residual-disease-after-definitive-therapy-in-orop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-pd-l1-inhibitor-continuation-or-rechallenge-after-first-line-progression-in-recurrent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/routine-prognostic-blood-tests-to-compare-survival-outcomes-with-low-dose-therapy-in-treatment-naive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimal-adjuvant-therapy-for-early-stage-cervical-cancer-escc-with-intermediate-risk-factors-a-ta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sustaining-oncology-clinical-trials-under-wartime-conditions-strategic-lessons-from-ukraine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-trial-of-the-anti-caprin1-antibody-trk-950-alone-or-with-nivolumab-in-japanese-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-molecular-features-and-treatment-of-primary-central-nervous-system-melano 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-involving-breast-cancer-and-chronic-lower-respiratory-diseases-among-postmenopausal-women 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proton-or-photon-comparative-survival-and-toxicity-outcomes-in-lung-cancer-radiotherapy-a-systemat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/timeliness-of-care-and-outcomes-in-thymic-epithelial-tumors-a-single-center-real-world-cohort-in-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-corticosteroid-exposure-on-efficacy-of-tarlatamab-in-small-cell-lung-cancer-a-multicent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quality-of-life-outcomes-following-hypofractionated-radiotherapy-in-locally-advanced-cervical-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-outcomes-by-her2-expression-in-locally-advancedmetastatic-urothelial-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spectrum-phase-ii-study-of-tislelizumab-plus-pemetrexed-in-patients-with-relapsed-or-refractory-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-impact-of-digitally-quantified-tumor-infiltrating-lymphocytes-in-hrher2-metastatic-bre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/low-density-lipoprotein-receptor-related-protein-1-overexpression-as-an-identifier-of-brain-metastas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-screening-and-detection-after-the-2024-uspstf-recommendation-for-women-aged-40-49 2026-08-24 monthly 0.7 https://rjrindex.com/articles/resolving-the-ambiguity-between-genomic-rearrangements-and-gene-fusions-an-ai-augmented-structural 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-pet-imaging-of-sup68sup-ga-fc516-a-nove 2026-08-24 monthly 0.7 https://rjrindex.com/articles/magma-multi-arm-glioblastoma-australasia-phase-3-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lung-cancer-incidence-and-pm-sub25sub-evaluating-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-to-treatment-for-primary-melanoma-in-an-integrated-healthcare-system 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pre-treatment-antibiotic-exposure-on-immunotherapy-outcomes-in-gastrointestinal-malignanci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-ugt1a1-polymorphism-on-safety-and-dose-management-of-sacituzumab-govitecan-in-the-treatmen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-mammary-adipocyte-diameter-and-survival-outcomes-in-breast-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serum-albumin-and-toxicity-burden-in-patients-with-solid-tumors-receiving-tyrosine-kinase-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-high-baseline-thymidine-kinase-1-activity-with-poor-prognosis-in-breast-cancer-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-endocrine-therapy-in-older-and-very-old-patients-with-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-an-integrated-statistical-framework-for-reconstructing-individual-patient-data-from-ti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-cancer-mortality-attributable-to-armed-conflict-a-gbd-1990-2021-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mapping-the-ovarian-cancer-diagnostic-journey-in-israel-results-from-a-qualitative-patient-and-clin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-mri-in-breast-cancer-diagnosed-over-age-70 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-overall-survival-with-mirvetuximab-soravtansine-compared-with-chemotherapy-after-multiple 2026-08-24 monthly 0.7 https://rjrindex.com/articles/general-population-interest-in-multi-cancer-early-detection-mced-testing-insights-from-a-seven-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-red-blood-cell-transfusion-versus-erythropoiesis-stimulating-agents-in-lung 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographic-disparities-in-availability-of-advanced-therapies-for-myeloma-from-rural-urban-access-lim 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-imatinib-real-world-mortality-patterns-across-modern-second-line-tkis-in-cml 2026-08-24 monthly 0.7 https://rjrindex.com/articles/estimated-prevalence-of-polycythemia-vera-in-the-united-states-2025-2030-seer-analysis-with-model 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-hepatic-arterial-infusion-chemotherapy-haic-plus-tislelizumab-tisle-combined-with-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-first-in-human-study-of-atx-295-an-oral-inhibitor-of-kif18a-in-patients-with-advanced-or-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-faecal-microbiota-transplantation-in-patients-with-advanced-pancreatic-carcinoma-fmtpanc-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/supporting-treatment-resilience-with-optimized-nutrition-and-guided-exercise-stronger-in-head-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/strategist-3-a-randomized-phase-3-study-of-velzatinib-idrx-42-versus-sunitinib-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/low-dose-vs-standard-dose-trastuzumab-deruxtecan-in-north-indian-patients-balancing-efficacy-toxi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-instability-score-gis-and-real-world-outcomes-in-patients-pts-with-advanced-ovarian-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-architecture-of-tenascin-c-driven-ecm-immune-niches-in-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/simultaneous-anthracycline-based-chemotherapy-and-dual-her2-blockade-in-early-stage-her2-positive-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/what-is-left-in-pmmrmss-braf-v600e-metastatic-colorectal-cancer-mcrc-prognostic-role-of-tumor-si 2026-08-24 monthly 0.7 https://rjrindex.com/articles/vimseltinib-vs-pexidartinib-an-indirect-comparison-of-response-rate-in-the-treatment-of-tenosynovi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-malignancy-in-dermatomyositis-vs-polymyositis-a-systematic-review-and-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regulatory-role-of-irf2-in-proliferation-and-invasion-of-nasopharyngeal-carcinoma-investigation-int 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-indicators-of-prostate-cancer-risk-in-a-community-based-screening-program-in-lagos-nigeria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-assessment-of-circulating-tumor-cells-ctcs-in-the-peripheral-blood-of-patients-with-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/activity-of-np-g2-044-fascin-inhibitor-anti-pd-1-in-ici-resistant-advancedmetastatic-solid-tumo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/features-of-the-content-of-components-of-the-vascular-endothelial-growth-factor-system-in-the-blood 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-from-sepsis-and-gastrointestinal-cancer-among-united-states-adults-a-cdc-wonder-ba 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-long-term-impact-of-a-public-cancer-screening-program-in-brazil-ten-years-of-experien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/navigated-embedded-supportive-care-via-telehealth-nest-a-community-partnership-model-for-rural-on 2026-08-24 monthly 0.7 https://rjrindex.com/articles/changes-and-significance-of-immune-related-indicators-in-patients-with-recurrentmetastatic-nasophar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-bevacizumab-biosimilars-in-metastatic-colorectal-cancer-a-pairwise-and-netwo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bevacizumab-based-triplet-versus-doublet-chemotherapy-as-first-line-treatment-for-metastatic-right-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proteomics-based-phosphorylated-akt-s473-and-pi3kakt-inhibitors-in-patients-with-hormone-receptor-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adverse-effects-associated-with-immune-checkpoint-inhibitors-in-locally-advanced-nasopharyngeal-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/indirect-calorimetry-and-estimated-energy-prescription-in-hospitalized-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-in-combination-with-bevacizumab-and-oral-cyclophosphamide-in-recurrent-platinum-resist 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-from-a-multi-institution-precision-oncology-tumor-board-the-promote-study-update 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-open-label-dose-finding-safety-tolerability-and-exploratory-trial-of-intraperitoneal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-recent-chemotherapy-exposure-on-overall-survival-in-patients-with-diffuse-large-b-cell-lym 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-access-to-precision-medicine-immune-checkpoint-inhibitor-ici-usage-in-non-small-cell-lung 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-relative-risk-to-lives-lost-meta-analysis-based-projection-of-invasive-fungal-infection-burden 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-associated-sepsis-hospitalizations-outcomes-inequities-and-palliative-care-national-inpati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-in-sudden-cardiac-death-among-patients-with-hematologic-malignancies-in-the-united-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/population-based-survival-and-demographic-disparities-in-acute-megakaryoblastic-leukemia-with-t122 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regorafenib-vs-apatinib-an-indirect-treatment-comparison-in-the-treatment-of-advanced-gastric-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/maintenance-pegylated-liposomal-doxorubicin-pld-versus-active-surveillance-for-advanced-soft-tissu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinico-genomic-landscape-of-indian-gallbladder-cancer-actionable-alterations-and-opportunities-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ivoloc-a-phase-ii-trial-of-ivonescimab-ivo-in-endocrine-refractory-hormone-receptor-hr-positive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intensive-chemotherapy-versus-venetoclax-hypomethylating-agents-therapy-for-acute-myeloid-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-of-oral-cavity-cancer-in-women-identifying-the-highest-risk-age-group 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-and-trends-of-cancer-and-attributable-risk-factors-in-women-1990-to-2023-with-projections-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-physical-exercise-on-psychological-status-and-evaluation-of-exercise-discussions-during-on 2026-08-24 monthly 0.7 https://rjrindex.com/articles/olverembatinib-in-philadelphia-chromosome-positive-acute-lymphoblastic-leukemia-meta-analysis-of-ef 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-profile-of-gastric-cancer-in-a-bolivian-cohort-a-retrospective-analysis-from-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-electronic-patient-reported-outcomes-epro-to-characterize-patients-with-acute-myeloid-leuke 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ptcy-abatacept-and-short-course-of-tacrolimus-cast-therapy-in-gvhd-prevention-in-mismatch-unrela 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-boost-for-oncology-care-delivery-improving-hospital-throughput-with-a-redesign-of-multidisciplina 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-of-ibrca1brca2i-mutations-in-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-5-year-survival-following-treatment-with-leronlimab-plus-physicians-choice-combination-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-trends-in-pembrolizumab-uptake-for-triple-negative-breast-cancer-tnbc-a-comparative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-validation-of-a-metabolomics-based-multi-cancer-early-detection-test 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-of-immune-checkpoint-inhibitor-rechallenge-in-patients-with-advanced-esophageal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-epidemiological-profile-and-overall-survival-by-age-adjusted-charlson-comorbidity-index 2026-08-24 monthly 0.7 https://rjrindex.com/articles/new-paradigm-for-antibiotic-selection-in-hard-to-treat-drug-resistant-infections-following-hsct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-characteristics-and-treatment-outcomes-of-advanced-high-grade-serous-ovarian-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insights-from-patients-with-early-stage-hormone-positive-breast-cancer-bc-using-an-artificial-int 2026-08-24 monthly 0.7 https://rjrindex.com/articles/daratumumab-plus-bortezomib-lenalidomide-and-dexamethasone-dvrd-in-patients-pts-with-newly-dia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-spatial-proteomics-to-identify-epithelial-cell-subtypes-driving-poor-prognosis-in-prostat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-shr-a2102-a-novel-nectin-4-targeted-antibody-drug-conjugate-in-combination-with-adeb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interim-analysis-results-from-duravelo-2-zelenectide-pevedotin-zele-bt8009-pembrolizumab-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-immunotherapy-combined-with-radiochemotherapy-vs-chemotherapy-alone-in-pmmr-colon-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-treatment-patterns-and-mortality-associated-with-glp1-ras-in-breast-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/individualized-radiosensitivity-guided-radiation-therapy-for-cervical-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-and-predictive-value-of-baseline-derived-neutrophil-to-lymphocyte-ratio-dnlr-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-a-novel-induction-regimen-polymeric-micellar-paclitaxel-plus-cisplatin-for-loca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-complement-atlas-of-head-and-neck-squamous-cell-carcinomas-to-reveal-intratumoral-complement-contr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/kitchen-radon-exposure-ventilation-behaviors-and-awareness-in-non-smoking-female-lung-adenocarcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hpv-vaccination-rates-in-new-mexico-and-future-directions-for-promoting-the-hpv-vaccine-among-young 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stratifying-survival-benefit-of-encorafenibcetuximab-ec-in-braf-v600e-mutant-mcrc-using-clinical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-perceptions-and-barriers-to-clinical-trial-participation-in-multicultural-communities 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-lung-cancer-and-renal-failure-related-mortality-in-the-united-states-1999 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-therapy-vs-standard-of-care-in-oral-cavity-squamous-cell-carcinoma-a-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-study-of-the-early-treatment-of-recombinant-human-thrombopoietin-for-chemoradiation-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/checkmate-901-association-of-tumor-and-peripheral-biomarker-profiles-with-durable-disease-control-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-genomic-profiling-to-identify-molecular-determinants-of-efficacy-of-idh1-inhibition-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cxcr4cxcl12-antagonism-to-disrupt-microenvironment-mediated-resistance-for-autologous-transplant-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/which-treatment-is-best-a-systematic-review-and-bayesian-network-meta-analysis-of-adjuvant-treatmen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-analysis-of-esym-a-cluster-randomized-trial-of-an-electronic-patient-reported-outc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/durvalumab-or-pembrolizumab-plus-gemcitabine-and-cisplatin-versus-gemcitabine-and-cisplatin-alone-as 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-associated-with-early-onset-versus-later-onset-pancreatic-cancer-a-systematic-review-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determinants-of-leadership-attainment-among-asco-leadership-development-program-2009-2025 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-ncdb-analysis-on-the-demographic-treatment-and-survival-of-nonkeratinizing-small-cell-squamous 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-treatment-sequence-of-immunotherapy-and-stereotactic-radiotherapy-on-survival-in-non-small 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-of-bgb-b2033-gpc3-x-4-1bb-bispecific-antibody-monotherapy-in-patients-with-selecte 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decomposing-the-co-mutational-landscape-of-nsclc-by-unsupervised-learning-to-unveil-components-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-resorcinol-isoprenyl-benzene-derivative-ipi201-on-natural-killer-cell-cytotoxicity-and-tu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/copernicus-a-pragmatic-phase-2b-study-of-subcutaneous-sc-amivantamab-ami-chemotherapy-chemo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pan-cancer-landscape-of-oncogenic-pole-and-pold1-alterations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomically-personalized-radiation-dose-de-escalation-a-phase-ii-basket-radiation-study-in-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamic-tumor-agnostic-ctdna-analysis-for-mrd-detection-and-longitudinal-monitoring-in-pleural-meso 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pin1-cholesterol-biosynthesis-and-clinical-outcomes-in-urothelial-carcinoma-uc-a-propensity-wei 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-rinse-to-result-feasibility-of-genotyping-core-biopsy-supernatant-in-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intismeran-autogene-to-induce-de-novo-neoantigen-specific-t-cells-as-adjuvant-therapy-in-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/is-adjuvant-chemotherapy-associated-with-improved-survival-for-patients-with-a-complete-pathological 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-neoadjuvant-immunotherapy-neoio-in-merkel-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-covid-19-mrna-vaccines-on-survival-outcomes-in-patients-with-solid-tumors-receiving-immuno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-artificial-intelligence-use-among-physicians-in-mexico-implications-for-oncology-practi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-upfront-surgery-versus-systemic-therapy-followed-by-surgery-in-patients-with-sy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-survival-after-chemotherapy-vs-no-chemotherapy-in-elderly-patients-with-pancreatic-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-polyadp-ribose-polymerase-inhibitor-use-and-overall-survival-in-united-states-veterans 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-tumor-informed-ctdna-monitoring-and-clinical-outcomes-in-advanced-urothelial-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-inectin4i-expression-inferred-from-circulating-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-based-multi-omics-analysis-to-identify-the-role-of-man1c1-in-pancreatic-cancer-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-vs-late-survival-patterns-of-chemoimmunotherapy-compared-with-immune-checkpoint-inhibitor-mono 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stereotactic-radiosurgery-srs-alone-vs-srs-whole-brain-radiotherapy-wbrt-for-1-4-brain-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-nasox-for-pancreatic-cancer-a-prospective-multicenter-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-impact-of-routine-mri-screening-for-brain-metastasis-in-patients-with-breast-cancer-a-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/desmocolin-3-directed-immunotherapy-in-recurrentmetastatic-head-and-neck-squamous-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-tislelizumab-plus-chemotherapy-versus-chemotherapy-in-mhc-ii-positivemhc-ii-negative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/linperlisib-plus-chop-for-newly-diagnosed-peripheral-t-cell-lymphoma-a-single-arm-phase-ibii-stud 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-rural-urban-disparities-in-us-cervical-cancer-mortality-before-and-after-the-hpv-vaccine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-sintart-1-and-sintart-2-two-phase-ii-trials-of-multimodal-treatments-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-of-a-novel-oncologist-led-diagnostic-algorithm-for-lynch-syndrome-in-colorectal-cancer-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precision-oncology-in-practice-real-world-multicenter-experience-with-larotrectinib-in-pediatric-ex 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-neural-correlates-of-chemotherapy-induced-peripheral-neurotoxicity-cipn-and-the-impact-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nanochemo-immunotherapy-of-er-positive-metastatic-breast-cancer-mbc-with-peg-liposomal-doxorubicin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiac-safety-of-aldoxorubicin-compared-to-doxorubicin-integrated-results-from-two-randomized-stud 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prognostic-impact-of-epilepsy-in-glioblastoma-insights-from-a-systematic-review-and-meta-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-survival-disparities-and-outcome-in-primary-vs-secondary-central-nervous-system-lymphoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-characteristics-treatment-patterns-and-outcomes-of-renal-cell-carcinoma-at-a-high-compl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-safety-profile-of-dendritic-cell-based-vaccination-in-melanoma-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-ai-integrated-patient-derived-organoid-platform-to-enable-high-throughput-drug-response-predictio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-social-environment-with-clinically-meaningful-declines-in-health-related-quality-of-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-12-study-of-etx-19477-an-oral-potent-and-selective-parg-inhibitor-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-changes-in-the-algebraic-connectivity-of-collateral-sensitivity-maps 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-depth-of-ipro-a-response-and-overall-survival-os-in-patients-with-advanced-non 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-static-and-dynamic-modulation-an-evaluation-of-rapidarc-dynamic-for-left-sided-chest-wa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-adjuvant-chemotherapy-initiation-delays-among-breast-cancer-patients-in-a-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamics-of-nectin-4-n4-expression-in-urothelial-carcinoma-uc-across-disease-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-nivolumab-in-addition-to-postoperative-radiation-therapy-in-locally-advanced-head-and-neck 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-transplant-on-itp53i-supmtsup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-3-study-apromiss-of-catequentinib-hydrochloride-al3818-monotherapy-in-patients-with-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-modal-ai-foundation-models-approach-for-diagnosis-of-myelodysplastic-syndromes-across-whole-bo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-predictors-of-response-to-cabazitaxel-in-metastatic-castration-resistant-prostate-cancer-mc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hampe-20-artificial-intelligence-driven-prediction-of-n256-glycosylated-ceacam56-expression-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/generalizable-cancer-detection-from-ultra-low-pass-whole-genome-sequencing-of-cell-free-dna-using-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-outpatient-palliative-care-for-patients-with-multiple-myeloma-a-randomized-pilot-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-impact-of-the-2021-uspstf-age-expansion-50-54-years-on-racial-disparities-in-early 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gabapentin-plus-intranasal-ketamine-for-the-prevention-and-treatment-of-pain-in-patients-undergoing 2026-08-24 monthly 0.7 https://rjrindex.com/articles/standardized-birth-rates-and-access-to-assisted-reproductive-technology-among-female-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/changes-in-the-incidence-of-second-malignant-neoplasms-in-neuroblastoma-over-time-an-updated-seer-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deep-learning-based-petct-radiomics-clinical-model-for-prognostic-stratification-and-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elisrasib-d3s-001-a-next-generation-gdp-bound-kras-g12c-inhibitor-as-first-line-therapy-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-fgfr3-pathway-activation-in-patients-with-muscle-invasive-bladder-cancer-treated-with-neoa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-randomised-controlled-trial-on-postoperative-radiotherapy-in-high-risk-resected-non-medu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/experience-of-spanish-centers-with-echoendoscopically-implanted-sup32sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/paclitaxelcisplatin-tp-vs-cisplatin5-fluorouracil-pf-neoadjuvant-chemoradiotherapy-for-locally 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-stigma-in-low-and-middle-income-countries-a-scoping-review-of-frameworks-measurement-appro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-to-identify-biomarkers-of-response-to-immunotherapy-in-ikras 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-evaluation-of-ai-assisted-documentation-and-summarization-in-virtual-multidisciplinary-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cs2009-a-novel-pd-1vegfctla-4-trispecific-antibody-in-patients-with-advanced-solid-tumors-updat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/profiling-patients-with-imeti-exon-14 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-prognostic-index-for-survival-prediction-in-ovarian-cancer-beyond-figo-staging 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prophylactic-tocilizumab-to-mitigate-cytokine-release-syndrome-in-patients-receiving-tarlatamab-a-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-prognoses-in-pancreatic-cancer-patients-receiving-neoadjuvant-therapy-versus-adjuvant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stereotactic-body-radiotherapy-versus-non-sbrt-radiotherapy-for-medically-inoperable-stage-i-non-sma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epigenetic-reprogramming-of-allogeneic-nk-cells-via-antigen-specific-training-to-generate-target-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-contemporary-practice-patterns-in-the-management-of-iidh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-omics-analysis-from-the-immucan-consortium-to-identify-predictors-of-chemo-immunotherapy-respo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-daraxonrasib-monotherapy-as-later-line-3l-treatment-for-patients-pts-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-study-of-ireti-fusion-in-patients-with-sol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-and-obesity-related-factors-in-breast-cancer-outcomes-a-systematic-review-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-and-safety-of-anti-her2-neoadjuvant-therapy-in-early-stage-her2-positive-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-the-er-cutoff-using-er50-to-define-a-distinct-her2-subgroup-characterized-by-low-pcr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sglt2-inhibitor-use-and-long-term-outcomes-in-anthracycline-treated-breast-cancer-a-real-world-retr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-characteristics-and-prognosis-of-pheochromocytomas-and-paragangliomas-ppgls-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapeutically-targetable-mutation-changes-in-lung-adenocarcinoma-metastasis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/failure-to-rescue-after-pancreatectomy-for-pancreatic-cancer-in-the-united-states-national-inpatien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/indole-alkaloid-corynan-isolated-from-ipetasites-hybridusi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-neoadjuvant-checkpoint-inhibitor-therapy-followed-by-definitive-chemoradiation-in-locall 2026-08-24 monthly 0.7 https://rjrindex.com/articles/coordinated-care-interventions-and-time-to-treatment-initiation-in-a-public-health-system-in-brazil 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathologic-features-of-invasive-lobular-breast-carcinoma-in-syria-an-epidemiological-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-immune-recovery-during-adjuvant-anti-pd-1-as-a-predictor-of-early-recurrence-in-resected-stage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-analysis-of-concomitant-opioid-usage-with-immunotherapy-in-recurrentmetastatic-head 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-sfrt-on-quality-of-life-in-patients-with-bulky-advanced-cancer-a-retrospective-single-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-review-of-the-first-three-years-of-a-pilot-colorectal-cancer-screening-program-in-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/olanzapine-versus-aprepitant-based-triple-antiemetic-regimens-for-the-prevention-of-chemotherapy-ind 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-reiki-as-an-integrative-supportive-care-intervention-at-a-comprehensive-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-statin-use-on-survival-in-patients-with-endometrial-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinicopathologic-characteristics-and-outcomes-of-msi-high-colon-cancer-in-community-onco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-care-outcomes-and-infectious-disease-insights-from-covid-19 2026-08-24 monthly 0.7 https://rjrindex.com/articles/features-of-euthyroid-disorder-syndrome-in-cancer-patients-with-different-tumor-localizations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systematic-safety-information-gaps-in-ai-generated-melanoma-therapy-information-an-exploratory-mult 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-phase-drug-development-in-oncology-geography-of-trials-including-us-vs-china 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ibiia-study-of-bat8010bat1006-an-anti-her2-monoclonal-antibody-exatecan-conjugate-combine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disproportionate-reporting-of-hepatic-injury-with-acute-leukemia-therapies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acute-kidney-injury-in-non-variceal-upper-gastrointestinal-bleeding-among-patients-with-gastric-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-context-matters-vision-transformer-based-dermoscopic-classification-of-skin-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-outcomes-with-pembrolizumab-and-chemotherapy-in-metastatic-metaplastic-triple-negative-bre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/axi-cel-vs-tisa-cel-vs-liso-cel-in-rr-dlbcl-meta-analysis-of-the-efficacy-safety-trade-off 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-global-multicenter-open-label-randomized-phase-3-registrational-study-of-lisaftoclax-apg-2575 2026-08-24 monthly 0.7 https://rjrindex.com/articles/keymaker-u01j-calderasib-plus-pembrolizumab-with-or-without-cetuximab-as-first-line-treatment-for-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/andrometa-lung-713-a-phase-23-study-of-telisotuzumab-adizutecan-abbv-400-temab-a-vs-standard-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/indocyanine-green-fluorescence-guided-navigation-during-gastrectomy-for-resectable-gastric-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/physician-ownership-and-investment-interests-in-oncology-a-national-analysis-of-open-payments-data 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-meta-analysis-of-perioperative-immunotherapy-modalities-in-patients-with-dmmrmsi-h-gastric-and-ga 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-serplulimab-combined-with-cisplatin-plus-5-fluorouracil-in-locally-advanced-head-and-nec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-i-study-of-ceb-01-a-biodegradable-sn-38-releasing-membrane-to-prevent-local-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-obesity-paradox-in-colon-cancer-hospitalizations-mortality-and-cardiovascular-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hydroxyurea-use-and-thrombotic-outcomes-in-myelofibrosis-patients-with-leukocytosis-a-propensity-ma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-fibrotic-progression-in-myeloproliferative-neoplasms-a-real-world-retrospective-cohor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/twenty-five-years-of-the-impact-mens-health-study-survivorship-health-behaviors-and-social-deter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interpretable-machine-learning-for-prognostic-survival-prediction-in-mycosis-fungoides-model-develo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-assessment-models-for-venous-thromboembolism-in-patients-with-multiple-myeloma-a-systematic-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-early-oncology-orphan-drug-designation-activity-following-expansion-of-the-orphan-dru 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tregcheck-102-a-study-of-tagmokitug-chs-114-in-combination-with-toripalimab-andor-other-treatmen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liver-transplantation-as-a-therapeutic-strategy-for-far-advanced-hepatic-malignancies-survival-outc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hipec-combined-with-nips-and-tislelizumab-for-conversion-therapy-in-gastric-cancer-with-peritoneal-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-and-safety-of-fgfr-inhibitors-in-intrahepatic-cholangiocarcinoma-a-trinetx-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-cachexia-and-wasting-phenotypes-in-relation-to-inpatient-severity-infection-resource-utiliz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-free-neoadjuvant-strategy-in-hrher2-early-breast-cancer-efficacy-of-cdk46-inhibito 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lucid-turning-clinical-noise-into-signal-structuring-oncology-data-at-scale 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-her2-testing-and-evidence-based-treatment-in-non-small-cell-lung-cancer-a-quality-improve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fruquintinib-alternating-with-bevacizumab-plus-capecitabine-as-maintenance-therapy-after-first-line 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multidisciplinary-ae-management-education-for-egfr-mutated-nsclc-mixed-methods-qi-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-immune-microenvironment-of-metastatic-hr-her2-breast-cancer-treated-with-cdk46-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-healthcare-professional-management-of-cdk46-inhibitor-adverse-events-and-variance-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/young-onset-prostate-cancer-in-the-real-world-a-single-institution-cohort-of-126-patients-diagnosed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inhalable-polyphenolic-based-nanoparticles-for-localized-lung-cancer-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/practical-prognostic-tool-for-personalising-first-line-alectinib-in-alk-positive-nsclc-a-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-her2-targeted-antibody-drug-conjugates-into-mucinous-ovarian-cancer-treatment-a-preclin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-serial-liquid-biopsy-egfr-mutation-monitoring-in-hispanic-patients-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-efficacy-of-cetuximab-after-immune-checkpoint-inhibitor-and-platin-failure-in-recurrentm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/brain-metastases-in-upper-gastrointestinal-tumours-a-multi-centre-retrospective-analysis-of-clinic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/allogeneic-hematopoietic-cell-transplantation-following-chimeric-antigen-receptor-t-cell-car-t-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cerebrovascular-mortality-in-patients-with-head-and-neck-cancer-in-the-united-states-1999-2023-a-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/itp53i-variant-allele-frequency-as-a-driver-of-survival-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-high-grade-biology-with-marked-salvage-refractoriness-following-cd19-car-t-cell-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-pre-treatment-hemoglobin-level-as-a-prognostic-factor-for-survival-outcomes-in-head-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-concurrent-covid-19-infection-with-in-hospital-outcomes-among-patients-hospitalized-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rethinking-risk-disparities-and-genetic-testing-outcomes-from-a-novel-public-facing-cancer-preventi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-effectiveness-and-healthcare-utilization-of-atezolizumab-plus-bevacizumab-versus-durvalu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/natural-history-of-weight-changes-in-pancreatic-cancer-a-longitudinal-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-venetoclax-with-and-without-azole-antifungals-in-acute-myeloid-leukemia-a-larg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/depeca-1-defeating-penile-cancer-1-a-phase-ii-study-to-evaluate-a-first-line-systemic-therapy-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ifct-2401-sporadic-trial-integrating-cemiplimab-to-sequential-hypofractionated-chemoradiotherapy-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nrg-gy036-a-phase-iii-trial-of-one-vs-two-years-of-maintenance-olaparib-with-or-without-bevacizum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/talent-a-randomized-phase-2-study-of-talazoparib-with-or-without-enzalutamide-in-patients-pts-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rejoice-ovarian01-phase-3-part-of-a-phase-23-study-evaluating-raludotatug-deruxtecan-r-dxd-versu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-2-study-to-evaluate-the-efficacy-and-safety-of-silevertinib-in-combination-with-tem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-satisfactory-testing-versus-transcript-grade-performance-between-childhood-cancer-survivo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-metastatic-sites-with-radiation-and-outcomes-in-high-risk-pediatric-rhabdomyosarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-fidelity-of-large-language-models-in-chronic-myeloid-leukemia-a-multimodel-comparative-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-changes-in-mortality-among-adults-with-breast-cancer-and-diabetes-mellitus-in-the-united-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-the-safety-efficacy-and-dosimetry-of-trc003-in-metastatic-castration-resistant-prosta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multimodal-risk-phenotyping-of-early-onset-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-large-prospective-patient-advocacy-assessment-of-fears-concerns-and-challenges-in-patients-diagn 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-single-arm-study-of-induction-ecep-plus-camrelizumab-followed-by-maintenance-camreliz 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interpretable-machine-learning-to-identify-health-system-levers-for-survival-outcomes-of-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deep-learning-based-classification-of-benign-and-malignant-breast-lesions-on-ultrasound-using-knowle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preoperative-assessment-of-peritoneal-carcinomatosis-with-sup68sup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exposure-response-e-r-analyses-of-efficacy-and-safety-with-raludotatug-deruxtecan-r-dxd-a-cdh6 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-patient-reported-stress-and-depression-symptoms-with-er-specific-tumor-transcriptiona 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-ai-paradox-in-precision-oncology-prospective-blinded-validation-of-large-language-models-agains 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-of-chatgpt-in-generating-patient-facing-cancer-survivorship-care-plans 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-molecular-characteristics-underlying-desmoid-tumor-clinical-trajectory 2026-08-24 monthly 0.7 https://rjrindex.com/articles/avelumab-sacituzumab-govitecan-ave-sg-vs-avelumab-monotherapy-ave-mono-as-first-line-1l-ma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-financial-toxicity-among-women-hospitalized-with-breast-cancer-in-the-united-states-2013 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pilot-trial-of-virtual-and-in-person-symptom-screening-with-targeted-early-palliative-care-step2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pilot-rct-of-a-patient-centered-communication-intervention-to-promote-values-based-treatment-decisio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/iopofosine-i-131-after-btk-inhibitors-in-waldenstrom-macroglobulinemia-clover-wam-subgroup-efficacy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-characteristics-and-results-reporting-among-oncology-clinical-trials-involving-african-countri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographical-heterogeneity-in-modeled-ca-125-kelim-values-insights-from-more-than-50000-real-world 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-the-phase-1-dose-escalation-and-expansion-study-of-alveltamig-zg006-a-trispeci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-dalpiciclib-combined-with-letrozole-and-dual-her2-blockade-in-hrher2-breast-cancer-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-efficacy-of-the-anti-ebv-agent-brincidofovir-bcv-in-ebv-associated-gastric-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decision-regret-and-toxicity-perception-following-adjuvant-pembrolizumab-in-renal-cell-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/new-paradigms-of-cancer-and-new-language-a-qualitative-study-exploring-language-around-goals-of-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-and-appraisal-of-quality-indicators-for-end-of-life-cancer-care-in-an-african-context 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conditional-survival-in-advanced-melanoma-treated-with-immune-checkpoint-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-atirmociclib-plus-letrozole-versus-letrozole-alone-in-hrher2-breast-cancer-results-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-radiotherapy-combined-with-lenvatinib-and-sintilimab-in-patients-with-resectable-hepatoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deciphering-the-genomic-landscape-of-renal-cell-carcinoma-brain-metastases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utidelone-in-heavily-pretreated-metastatic-castration-resistant-prostate-cancer-progressing-after-do 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-the-impact-of-gold-and-silver-signals-on-eras-applications-a-survey-of-hematologyonc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deep-learning-based-computer-aided-detection-and-diagnosis-system-for-malignant-biliary-stricture-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-yl201-an-anti-b7h3-antibody-drug-conjugate-adc-in-heavily-pretreated-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/secondary-safety-analysis-of-trastuzumab-deruxtecan-t-dxd-vs-trastuzumab-emtansine-t-dm1-in-dest 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-datopotamab-deruxtecan-dato-dxd-vs-chemotherapy-in-patients-with-locally-recurrent-inop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sarm1-inhibition-to-prevent-chemotherapy-induced-peripheral-neuropathy-translational-and-early-clin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-multicenter-single-arm-clinical-trial-of-response-adapted-definitive-radiotherapy-and-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-progression-treatment-tx-analyses-of-evera-breast-cancer-bc-a-phase-iii-trial-of-giredestr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-pharmacovigilance-analysis-for-antibody-drug-conjugates-adcs-in-treatment-of-solid-tumo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retracted-neoadjuvant-adebrelimab-plus-chemotherapy-in-untreated-locally-advanced-head-and-neck-squ 2026-08-24 monthly 0.7 https://rjrindex.com/articles/converge-01-part-3-ac-225-rosopatamab-tetraxetan-conv01-a-in-lu-psma-pretreated-metastatic-castra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-linvoseltamab-versus-teclistamab-in-triple-class-exposed-tce-relapsedrefr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-multi-cancer-early-detection-into-cancer-screening-programs-in-the-united-states-a-cost 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-in-veterans-with-metastatic-hormone-sensitive-prostate-cancer-by-initial-therapy-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/late-infectious-complications-after-cd19-directed-chimeric-antigen-receptor-t-cell-car-t-therapy-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pancreatic-cancer-incidence-and-survival-in-lean-and-obese-adults-with-type-2-diabetes-a-propensity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-ipos-to-trigger-advance-care-planning-in-outpatient-palliative-oncology-a-multicenter-real-wo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/texture-and-color-enhancement-imaging-txi-for-polyp-detection-in-colorectal-neoplasia-screening-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-transcriptomic-analysis-of-chemotherapy-naive-and-post-chemotherapy-germ-cell-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-dose-escalation-trial-of-an-engineered-salmonella-delivering-l-methioninase-in-advanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/influence-of-neoadjuvant-therapy-on-tumor-vascular-immune-stromal-networks-in-colorectal-cancer-live 2026-08-24 monthly 0.7 https://rjrindex.com/articles/five-year-follow-up-of-neoadjuvant-chemoimmunotherapy-in-locally-advanced-head-and-neck-squamous-cel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detection-quantification-and-subtyping-of-adenoid-cystic-carcinoma-acc-using-methylation-from-li 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serum-her2-level-as-a-predictor-of-treatment-efficacy-and-prognosis-in-advanced-breast-cancer-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-translation-leveraging-interpreter-expertise-to-enhance-clinician-training-and-language-equi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/minimal-residual-disease-mrd-assessment-by-circulating-tumor-dna-ctdna-to-stratify-recurrence-ri 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-probiotics-combined-with-glutamine-compound-for-acute-radiation-enteritis-during-neoadju 2026-08-24 monthly 0.7 https://rjrindex.com/articles/primary-results-from-the-triple-negative-cohort-of-tbcrc-053-p-rad-a-randomized-trial-of-no-low 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-clinical-and-translational-results-of-olverembatinib-hqp1351-in-patients-with-succinate-de 2026-08-24 monthly 0.7 https://rjrindex.com/articles/from-treatment-to-survivorship-the-core-randomized-study-of-a-supervised-exercise-intervention-in-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-differences-between-early-and-later-onset-colorectal-cancer-in-a-chilean-cohort-a-retros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hrd-positive-breast-cancer-genomics-cross-application-of-ovarian-cancer-hrd-scores 2026-08-24 monthly 0.7 https://rjrindex.com/articles/applying-a-large-language-model-to-detect-immune-related-adverse-events-in-electronic-health-records 2026-08-24 monthly 0.7 https://rjrindex.com/articles/who-really-benefits-from-chemotherapy-in-high-risk-localized-soft-tissue-sarcoma-a-virtual-twin-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differentiating-donor-age-on-aml-patient-outcomes-in-the-post-transplant-cyclophosphamide-contempora 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-informed-versus-tumor-agnostic-ctdna-assays-for-molecular-residual-disease-detection-in-colore 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-between-dual-fdgpsma-pet-mismatch-and-ctdna-genomic-profiling-in-metastatic-castration 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intravenous-oncolytic-virus-idov-safe-in-pmmrmss-metastatic-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-an-oncology-generative-ai-foundation-model-trained-on-more-than-a-million-longitudina 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantitative-results-from-psmatrack-a-prospective-study-evaluating-changes-in-psma-pet-during-initi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rare-histologic-subtypes-of-triple-negative-breast-cancer-the-impact-of-immunotherapy-on-outcomes-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-from-the-phase-2-izalco-study-efficacy-and-safety-of-isatuximab-subcutaneous-plus-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-influence-of-exercise-on-the-mediational-relationship-between-chemotherapy-induced-sensory-neuro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/premature-cancer-mortality-in-the-united-states-1999-2023-analysis-of-cdc-wonder-data 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-organization-of-immune-surveillance-by-germline-mutation-status-in-the-breast-cancer-family 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reproducible-modulation-of-tissue-ki-67-across-lung-and-prostate-cancer-interception-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intralesional-pd-1-blockade-for-oral-cancer-prevention-first-in-class-phase-1-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/minimal-residual-disease-dynamics-in-newly-diagnosed-multiple-myeloma-and-impact-on-progression-free 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-common-gene-expression-signature-across-multiple-myeloma-disease-stages-to-identify-high-risk-of-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-context-modeling-with-vision-transformers-for-mri-based-classification-of-brain-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-and-sociodemographic-differences-in-influenza-vaccination-among-us-cancer-survivor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-efficacy-safety-and-exploratory-biomarker-analyses-of-a-phase-ii-trial-of-abemaciclib-plus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-intravenous-immunoglobulin-use-in-multiple-myeloma-patients-treated-with-talquetamab-effect-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/egfr-tyrosine-kinase-inhibitor-plus-angiogenesis-inhibitor-combination-therapy-in-treatment-naive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-targeted-axillary-dissection-on-axillary-lymph-node-dissection-rates-compared-with-sentine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-machine-learning-model-for-predicting-recurrence-and-survival-in-stage-i-iii-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/construction-of-an-in-vitro-peritoneal-metastasis-model-and-evaluating-its-feasibility-for-experimen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dexamethasone-associated-hyperglycemia-during-chemotherapy-in-endometrial-and-ovarian-cancer-a-retr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/emergency-presentation-as-a-diagnostic-failure-phenotype-in-ovarian-cancer-a-national-inpatient-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-related-differences-in-patient-burden-in-endometrial-cancer-findings-from-the-international-exp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarker-driven-prescribing-patterns-in-iesr1i-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shallow-whole-genome-sequencing-genomic-instability-score-across-endometrial-cancer-subtypes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/glucose-6-phosphate-dehydrogenase-deficiency-and-skin-cancer-a-retrospective-study-assessing-cutane 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-efficacy-and-mechanisms-of-action-of-seriniquinone-against-pediatric-neuroblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nanoscale-spatial-profiling-of-dll3-sez6-and-b7-h3-in-small-cell-lung-cancer-using-a-rapid-expansi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/remote-physical-activity-intervention-for-young-hispanic-breast-cancer-survivors-with-persistent-pos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhanced-pre-biopsy-risk-stratification-for-aggressive-prostate-cancer-using-prostate-density-in-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/electrolyte-abnormalities-and-severity-mortality-and-resource-utilization-in-us-cancer-hospitali 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-research-based-initiative-to-coordinate-care-for-patients-with-basal-cell-carcinoma-and-cutaneous 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-reported-digital-symptom-monitoring-and-actionable-triage-in-oncology-a-scoping-systematic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-and-regional-economic-burden-of-alcohol-attributable-cancers-a-benchmarking-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-immune-mediated-hepatitis-with-immune-checkpoint-inhibitor-regimens-in-advanced-hepat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-health-systems-analysis-of-global-head-and-neck-cancer-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-trial-in-progress-phase-iii-study-of-tebentafusp-in-combination-with-liver-directed-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-rate-of-msi-highdmmr-gastric-esophageal-and-gastroesophageal-junctional-adenocarcinoma-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/definitive-non-surgical-management-of-locally-advanced-esophageal-adenocarcinoma-a-systematic-revie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-future-of-oncology-research-replacing-case-report-forms-with-mcode-aligned-electronic-health-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-single-arm-trial-of-low-dose-capecitabine-in-patients-with-advanced-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-mortality-involving-esophageal-cancer-with-comorbid-psychoactive-substance-induce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-patterns-of-venetoclax-based-regimens-for-aml-in-a-community-based-setting-and-represent 2026-08-24 monthly 0.7 https://rjrindex.com/articles/net-clinical-value-of-neoadjuvant-immune-checkpoint-inhibitors-in-early-triple-negative-breast-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-reflex-molecular-analysis-to-preserve-clinically-actionable-targets-in-lung-cancer-regard 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-urothelial-bladder-cancer-ubc-a-retrospective-multicenter-analysis-from-pe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-cancer-specific-survival-of-estrogen-receptor-negative-progesterone-receptor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/workforce-availability-for-cancer-surgery-in-rural-areas-a-collaboration-with-the-american-board-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-and-clinicopathological-characteristics-of-patients-with-metaplastic-breast-cancer-at-the-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-cadonilimab-plus-chemotherapy-and-bevacizumab-as-second-line-treatment-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-among-older-diabetic-patients-with-lung-cancer-in-the-united-states-1999-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/barriers-and-facilitators-to-multidisciplinary-head-amp-neck-cancer-care-coordination-in-tanzania 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-an-audiovisual-educational-intervention-on-gastric-cancer-knowledge-and-health-literacy-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-onset-colorectal-cancer-2-year-analyses-of-georgian-cancer-registry 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-onset-colorectal-cancer-hospitalizations-in-the-united-states-metastatic-burden-comorbidity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-hpvs-influence-on-survival-in-head-and-neck-cancer-a-pioneering-large-scale-cohort-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-artificial-intelligence-based-framework-for-longitudinal-risk-prediction-in-patients-with-cirrhos 2026-08-24 monthly 0.7 https://rjrindex.com/articles/helicobacter-pylori-infection-systemic-inflammation-and-colorectal-cancer-a-prospectively-enrolle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/endometrial-cancer-mortality-among-postmenopausal-women-in-the-united-states-1999-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insights-from-an-artificial-intelligence-ai-powered-cancer-navigation-platform-digital-support-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/golcadomide-golca-a-potential-first-in-class-oral-celmod-plus-rituximab-r-versus-investigato 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nrg-hn015-a-phase-ii-randomized-trial-of-neoadjuvant-chemotherapy-or-chemo-immunotherapy-in-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frameworks-for-improving-comprehensive-biomarker-testing-in-nsclc-a-multi-stakeholder-consensus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrating-multimodal-data-with-artificial-intelligence-to-predict-postoperative-recurrence-in-intr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sociodemographic-disparities-and-clinical-outcomes-in-chimeric-antigen-receptor-car-t-cell-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/reducing-stress-and-improving-quality-of-life-for-adult-breast-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-sacubitrilvalsartan-for-prevention-of-anthracycline-related-cardiotoxicity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/state-level-trends-in-colorectal-cancer-incidence-and-stage-before-and-during-the-covid-19-pandemic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bone-marrow-vascular-architecture-implications-for-targeting-bone-marrow-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemotherapy-with-nalirifox-for-locally-advanced-colorectal-cancer-a-multicenter-singl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/significance-of-marrow-complete-remission-mcr-in-higher-risk-mds-a-meta-regressive-assessment-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deconstructing-implementation-of-reflex-biomarker-testing-in-non-small-cell-lung-cancer-nsclc-div 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiotoxicity-and-efficacy-outcomes-of-spedox-6-for-targeted-treatment-of-soft-tissue-sarcomas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sensitivity-detection-of-colorectal-precancerous-lesions-and-cancer-by-assessing-cell-free-multimoda 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-rule-based-matching-a-locally-deployable-retrieval-augmented-framework-for-clinical-trial-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-neoadjuvant-ici-based-regimens-in-resectable-gastric-and-gej-cancer-updated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nodal-station-mapped-recurrence-patterns-after-neoadjuvant-immunochemotherapy-and-r0-esophagectomy-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-agnostic-ctdna-methylation-profiling-as-an-enabler-of-preoperative-risk-stratification-and-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/viral-vs-non-viral-combined-hepatocellular-cholangiocarcinoma-distinct-genomic-landscapes-and-survi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ncorp-symptom-science-portfolio-analysis-2014-2025 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-dependent-survival-gradients-and-projected-future-disease-burden-in-adult-acute-lymphocytic-leuk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/automated-identification-of-phenotypically-aberrant-cells-in-acute-myeloid-leukemia-mrd-an-unsuperv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-inpatient-cancer-diagnostic-service-an-academic-cancer-center-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/difference-in-differences-analysis-of-age-specific-survival-gains-in-acute-myeloid-leukemia-followin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-chemotherapy-immunotherapy-and-chemoradiation-in-esophageal-cancer-a-trinetx-real-wor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-impact-of-metabolic-renal-and-demographic-factors-on-overall-survival-in-well-to-moder 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-ehr-embedded-smartform-oncassessment-paired-with-epros-to-enable-real-time-structured-documenta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liquid-biopsy-at-the-finish-line-end-of-treatment-ctdna-predicts-relapse-and-survival-in-diffuse-la 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-single-arm-exploratory-study-of-gemox-combined-with-tislelizumab-and-donafenib-in-the-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarker-study-of-bnd-22-in-combination-with-cemiplimab-in-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-first-line-immune-checkpoint-inhibitor-combinations-versus-tyrosine-kinase-inhibitors-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-ii-study-of-amivantamab-lazertinib-versus-afatinib-in-patients-with-uncommoncomp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/carefol-a-phase-3-randomized-open-label-multicenter-trial-of-camrelizumab-and-rivoceranib-with-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fuel-it-lung-fasting-to-unleash-and-enhance-lung-cancer-immunotherapy-a-va-lung-precision-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rare-germline-heterozygous-pathogenic-blm-variants-and-correlations-with-co-occurring-pathogenic-var 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-associated-genomic-instability-and-inflammatory-pathway-activation-a-pan-cancer-multi-omics-ana 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combination-synergy-of-spliceosome-modulator-adc-with-a-k-ras-inhibitor-in-ik 2026-08-24 monthly 0.7 https://rjrindex.com/articles/decoding-spatial-tumor-heterogeneity-via-multi-view-radiomics-for-long-term-survival-prediction-in-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cerebrospinal-fluid-cell-free-tumor-dna-based-cancer-molecular-profiling-vs-cytology-examination-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-cs2009-a-first-in-class-pd-1vegfctla-4-trispecific-antibody-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhanced-detection-of-clinically-actionable-non-v600-ibrafi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/resistance-mechanisms-and-efficacy-of-first-line-alectinib-and-sequential-treatments-in-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-third-generation-allosteric-sting-agonist-crd3874-si-a-novel-immunotherapy-in-patients-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-lnp-mrna-based-in-vivo-cell-engager-as-a-producer-of-t-macrophage-tumor-triads-in-situ-for-target 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-characteristics-treatment-patterns-and-survival-in-a-metastatic-pancreatic-adenocarcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-study-of-pomalidomide-and-nivolumab-pomnivo-in-patients-with-virus-associated-malignanc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/luvometinib-in-adults-with-neurofibromatosis-type-1-and-symptomatic-inoperable-plexiform-neurofibro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-of-dual-checkpoint-inhibition-nivolumab-ipilimumab-versus-anti-pd-1-monother 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemo-immunotherapy-chemo-ici-versus-chemotherapy-chemo-alone-as-a-first-line-therapy-1l-in-ex 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicogenomic-characterization-of-muc16-and-muc17-in-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/agibot-am1000-versus-da-vinci-xi-systems-for-robot-assisted-partial-nephrectomy-a-retrospective-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utility-of-hemoglobin-a1c-and-blood-glucose-monitoring-for-early-detection-of-pancreatic-cancer-in-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/appendiceal-cancer-historical-trends-in-histological-composition-and-cause-specific-mortality-based 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prior-ctla-4-blockade-as-associated-with-a-hyperactive-immunosuppressive-signature-and-limited-respo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-biomarker-testing-to-predict-outcomes-in-gliomas-a-seer-registry-study-in-kentucky 2026-08-24 monthly 0.7 https://rjrindex.com/articles/projected-burden-of-lung-cancer-and-tobacco-usage-among-older-adults-65-in-the-united-states-a-cd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-results-from-the-first-in-human-phase-1-study-of-wee1-inhibitor-apr-1051-in-patients-with-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-validation-of-an-ai-based-prognostic-assay-for-stage-i-ii-cutaneous-melanoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-and-prognosis-of-pembrolizumab-combination-in-neoadjuvant-chemotherapy-for-triple-negative-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/three-decade-trends-in-bladder-cancer-burden-in-the-middle-east-and-north-africa-divergent-patterns 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-lineage-defining-transcription-factors-foxa1-and-pou2f3-as-markers-of-poor-prognosis-across-two 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-treatment-patterns-of-advanced-non-small-cell-lung-cancer-in-patients-with-and-without-pr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anti-tumor-activity-of-ff-10850-liposomal-topotecan-in-patients-with-advanced-merkel-cell-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-immune-checkpoint-inhibitor-backbones-in-istk11keap1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/physician-preferences-for-metastatic-hormone-sensitive-prostate-cancer-treatment-a-discrete-choice 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hla-a01-as-a-biomarker-of-poor-outcome-in-patients-treated-with-immune-checkpoint-inhibitors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-evaluation-of-intrathecal-trp1-targeted-car-t-cells-effects-on-durable-antitumor-immuni 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fapi-cup-a-prospective-cohort-study-of-patients-with-cancer-of-unknown-primary-cup-to-evaluate-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-kynurenine-tryptophan-levels-and-their-ratio-in-lung-cancer-a-meta-analysis-revealing 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-the-toxicity-profile-of-different-adt-arpi-combinations-in-prostate-cancer-pc-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-dual-inhibition-of-inos-and-cox2-on-antitumor-immunity-and-response-to-immune-checkpoint-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/timing-of-postoperative-chemoradiotherapy-and-survival-outcomes-in-high-risk-locally-advanced-head-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-gut-microbiome-and-treatment-outcomes-in-metastatic-pancreatic-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-cadonilimab-cd-in-combination-with-disitamab-vedotin-rc48-or-nab-paclitax 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hepatic-arterial-infusion-chemotherapy-plus-either-toripalimab-or-sorafenib-as-first-line-therapy-fo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-the-breast-cancer-index-on-extended-endocrine-therapy-recommendations-in-patients-from-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hetrombopag-plus-caffeic-acid-tablets-for-the-treatment-of-chemotherapy-induced-thrombocytopenia-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exosomal-mirna-signatures-as-predictors-of-response-to-neoadjuvant-folfirinox-and-gemnab-paclitaxel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhanced-predictive-value-of-kelim-for-surgical-resectability-in-hrd-positive-high-grade-serous-ovar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iib-randomized-trial-of-folfirinox-plus-ibrilatazar-abtl0812-versus-placebo-as-first-line-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-ai-guided-questioning-versus-standard-information-delivery-in-a-simulated-newly-diagno 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-cohort-validation-of-a-multi-analyte-liquid-biopsy-test-for-early-stage-pancreatic-cancer-dete 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-a-remote-electronic-assessment-of-survivors-with-tailored-follow-up-recommendations-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-resolved-cardiovascular-risk-after-immune-checkpoint-inhibitors-a-large-real-world-cancer-coho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-a-novel-blood-based-lung-nodule-triage-test-in-elevated-risk-subjects 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identifying-cancer-cachexia-using-clinical-reasoning-artificial-intelligence-ai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/achieving-epidemiologically-representative-enrollment-and-social-determinants-of-health-in-the-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nab-paclitaxel-plus-s-1-induction-chemotherapy-for-patients-with-locally-advanced-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-a-novel-diagnostic-kit-using-the-semi-dry-dot-blot-method-with-an-automated-reader-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-study-of-guideline-concordance-in-cervical-cancer-screening-surveillance-by-age-race 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-microenvironment-signatures-as-prognostic-biomarkers-in-gastroenteropancreatic-neuroendocrine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pan-cancer-discovery-of-clinical-and-genomic-determinants-of-immune-related-adverse-events 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-powered-assessment-of-tertiary-lymphoid-structures-tls-from-hampe-whole-slide-images-as-a-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-hlx43-an-anti-pd-l1-adc-in-previously-treated-recurrentmetastatic-nasophar 2026-08-24 monthly 0.7